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 ABSTRACT 
 
Two outbreaks of sheeppox that occurred in Gedarif State in June 2003 and one 
outbreak of goatpox that occurred in Khartoum State in March 2005 were investigated. 
Clinical signs were reported, morbidity rates were estimated and the total mortalities 
were recorded. Clinically, the disease was characterized by fever, depression and eruption 
of generalized pox lesions. Mortality rate ranged between 5.2 and 6.7 with a mean of 6.1. 
All age, sex and breed groups were affected. However, more than 50% of deaths were 
reported in young animals in comparison to adult sheep.  
Skin Scabs were collected from sick animals, homogenized and inoculated in cell 
culture and embryonated eggs. Two virus isolates were obtained when 4 skin samples 
were inoculated onto Lamb testes (LT) cell culture. These viruses as well as one previous 
isolate of sheeppox virus (SP4) and the vaccine strain 0240 induced no lesions on the 
chorioallantoic membrane (CAM) of embryonated chicken eggs. 
On the other hand, sheeppox and goatpox isolates grew well in lamb testes (LT) 
cell culture with no difference in virus yield or type of CPE produced by the two viruses. 
In Vero cells, both viruses produced more than 90% CPE within 7 days PI. In MDBK 
however, both viruses induced slight CPE that reached 60% in 9 days. On the other hand, 
both viruses induced no CPE in chick embryo fibroblast (CEF) cells. 
Titration of an isolate of sheeppox virus (SP1O) was performed in Vero cells and 
resulted in a titer of 105.2/ml.  The same virus was identified as sheeppox in virus 
neutralization test with 1.4 neutralization index. 
Polymerase chain reaction (PCR) was used in this study to determine the 
feasibility of improving diagnosis of sheep pox and goat pox in scabs collected from the 
field as well as in supernatant of infected cell cultures.  Three methods of DNA extraction 
were tried. The first method (PCR 1) employed no DNA extraction step with scab 
homogenate or cell culture supernatant added directly to the PCR mix.  This method 
failed to detect pox virus DNA in all scab homogenates tested but three out of six cell 
culture supernatants gave positive results. In the second method (PCR 2), viral DNA was 
extracted by phenol-chloroform from skin scabs; three samples out of six gave positive 
results. In the third method (PCR 3), viral DNA was extracted using a commercial DNA 
extraction Kit; two out of three gave positive result. Accordingly, the best PCR method 
for sheeppox and goatpox diagnosis should include an initial step of DNA extraction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
.    
Introduction 
 
Capripoxviruses are the most important poxviruses of animals, causing diseases in 
sheep, goats, or cattle respectively. These viruses are responsible for some of the most 
economically significant diseases of domestic ruminants in Africa and Asia. Sheeppox 
and goatpox exhibit similar clinical signs that are typical generalized pox viral disease, 
including pyrexia, cutaneous lesions, and notably the development of lung lesions 
(Esposito and Fenner, 2001; Munz and Dumbell, 1994).  
In the Sudan the presence of sheeppox had been confirmed since 1940 (Bennet et 
al., 1944), and it has remained enzootic as well as in most part of Africa. Sheeppox in the 
Sudan was generally known to be a seasonal disease associated with the cold winter 
(Muzichin and Ali, 1979), however, in last few years outbreaks of the disease were 
observed at different times of the year. Goatpox has also been confirmed in the Sudan 
and caused severe diseases in both goats and sheep  
Efforts for prophylaxis against sheeppox has begun in the Sudan since the eighties 
of the last century when the 0240 vaccine strain of Kenya sheep and goatpox virus was 
brought in the country (Ali & Hajer, 1989). However, the occurrence of sheeppox in 
some vaccinated animals has also been reported by some stock owners (Sheikh Ali, 
1997). It is therefore, important to determine the immunogencity of the vaccine in use vis 
the pathogencity of the local isolates of the virus. As a prerequisite for this approach field 
outbreaks should be investigated to determine the epidemiology of the disease and the 
causative agent should be isolated and characterized. 
All strains of sheeppox virus and goatpox virus examined so far are antigenically 
similar and share a common neutralizing site irrespective of their geographical origin.
 The diagnosis of goatpox and sheeppox is usually based on clinical signs followed 
by laboratory confirmation. Initially, the laboratory test was mainly confined to agar gel 
precipitation, for which conventionally produced hyperimmune sera against GPV and 
SPV were used, subsequently, a soluble antigen fraction, which is not infectious, has 
efficiently replaced the infectious virus in various serological tests. This soluble antigen 
is commonly used in diagnostic tests and can avoid the risk of spread of virus from the 
laboratory.     
Diagnosis of SPV and GPV is made by identification of Capripoxvirus by virus 
isolation on cell culture and confirmation by virus neutralization or immunoflourscence 
using hyperimmune anti Capripoxvirus serum. Capripoxvirus isolation is a lengthy 
procedure due to the slow growth of the virus in cell culture, in which cytopathic effects 
may take up to 10 days to develop (Plowright and Ferris, 1958). Serology is limited in its 
application due to often low antibody response following infection. Another problem, 
which occurs when serological diagnosis is undertaken, is that Capripoxvirus and 
Parapoxvirus are related closely serologically. Both viruses cause very similar diseases in 
sheep and goats and it is difficult to differentiate them clinically. Many serodiagnostic 
assays, such as, agar gel immunodiffusion, complement fixation, counter 
immunoelectrophoreses or ELISA, because they detect total antibody response including 
that from cross-reactive antibodies, are not reliable for differentiation between these 
infections. 
The most specific classical technique, virus isolation on susceptible cell cultures 
followed by confirmation (virus neutralization or immunoflourscence using 
hyperimmune anti Capripox serum) is a lengthy procedure and may take up to 2 weeks. 
  These diagnostic problems can be overcome by the use of PCR, which is specific, 
rapid, sensitive and accurate assay for the detection of Capripoxviruses. 
Recently, various PCR methods for detection and diagnosis of sheep and goatpox 
virus infection were developed (Ireland and Binepal, 1998; Heine et al., 1999; Mangana-
Vougiouka et al., 1999; Parthiban et al., 2005).  
The purpose of the study is to introduce polymerase chain reaction (PCR) for 
rapid diagnostic technique of sheep and goatpox virus infections in the Sudan.  
 
 
 
 
 
 
CHAPTER I 
LITERATURE REVIEW 
 
 
1.1. Sheep and goats production in Sudan 
Sheep and goats are considered as an important group of animals in Sudan, the 
total population of sheep was estimated to reach more than 30 million head goat was 
more than 20 million head (Ministry of Animal resources), distributed all over the Sudan 
specially in the eastern, middle and western states of Sudan. The most important breeds 
of sheep and goats in Sudan can be mentioned as follow: Desert sheep, Gezera and 
buttana breeds (Ashgar, Abbrag, Dubasi and Garagi) Watteish breed, Kabbashi breed, 
Elmedobe beerd, Beeja breed, West Africa breed (Zagawa and Faullani or Fallata sub-
breeds), Nilotic breed and Fat tailed breed (equatorial region). Goat breeds in Sudan 
include the Sudanese Nubian goat breed and the Sudanese desert goat breed (Elazaiem. 
1993). 
 
1.2. Importance of sheep and goat pox diseases 
Sheep and goatpox diseases are a weighty problem in sheep and goats production. 
In fact they are most serious of all pox diseases of domestic animals. Regarding sheep 
and goats production and economy, the importance of the diseases lies in the high 
morbidity, mortality in young animals, partial loss of reproduction function and damage 
to wool and hair. 
 
1.3. Definition 
1.3.1. Sheeppox 
Sheeppox is a contagious disease of sheep caused by sheeppoxvirus (SPV). It is 
considered one of the most dangerous poxvirus infections among animals. The disease is 
characterized by a rise of body temperature and skin lesions in the areas denied of wool; 
the disease may also affect the mucous membranes of the respiratory and gastrointestinal 
tracts. Sheep are the natural host of the virus; affection is determined by age and breed 
(Jubb and Kennedy, 1970; Buxton and Fraser, 1977). 
1.3.2. Goatpox 
Goatpox is caused by goatpoxvirus (GPV) which is closely related to sheeppox 
virus; clinically it resembles sheeppox but the disease in goats takes a mild course (Merza 
and Mushi, 1990). 
 
1.4. History and distribution of SPV and GPV 
Hansen first reported goatpox in 1879 from Norway (Rafyi and Ramyar, 1959). 
Later, it was observed during the period of the First World War in Macedonia, where it 
became enzootic during the year 1926, with a mortality rate of 15% (Blanc et al., 1928). 
The disease is present mainly in Asia, Africa, the Middle East and parts of 
Europe, but it has also been reported from many other parts of the world, e.g. southwest 
Africa (Zeller, 1920), France (Besnoit and Robin, 1923), Malaysia (Kuppuswamy, 1936), 
Norway (Slagsvold, 1938), Morocco (Grimpret, 1938), Tajikistan (Vannovski, 1955), 
Sweden (Bakos and Brag, 1957), Sudan (Mohamed et al., 1982), Iraq (Karim, 1983), 
Nigeria (Okaiyeto et al., 1995), the western USA (Renshaw and Dodd, 1978), the 
Republic of China, Bangladesh, the Yemen Arab Republic and Oman (Kitching et al., 
1986a). In India, an outbreak of goatpox was reported for the first time in 1936 (Imperial 
Institute of Veterinary Research, 1936–37). Later it was reported from the states of 
Haryana (Lall et al., 1947), Uttar Pradesh (Das et al., 1978), Orissa (Bandyopadhyay et 
al., 1984) and West Bengal (Saha et al., 1985), and recently from Madhya Pradesh (Joshi 
et al., 1999).Sheeppox has a documented history almost as long as that of smallpox. 
 The disease was apparently present in Asia and Europe as early as the second 
century AD (Hutyra et al., 1946), and its infectious nature was recognized in the mid-
eighteenth century. Eradication was achieved in Britain in 1866, but in other areas of 
Europe eradication was more difficult, probably because of the extensive livestock trade 
between countries (Fenner et al., 1993).  
The disease has also been reported from Niger (Mariner et al., 1991). In India, the 
first report of the prevalence of sheeppox came from Tamil Nadu, Bombay and United 
Provinces (Sathe, 1931–32) and from Mysore (now Karnataka) in 1936 (Srikantaiah, 
1936). Minnet (1949) described the occurrence of the disease, which caused considerable 
economic loss throughout the country through mortality and permanent damage to the 
skin in affected sheep. Subsequently, there have been several reports of pox in sheep 
from different parts of the country (Murthy and Singh, 1971; Sharma et al., 1986; Rao et 
al., 1994). The disease is still reported (Malik et al., 1998) despite the availability of an 
efficient vaccine in India, which raises doubt about the effectiveness of the vaccination 
regimen being followed.   
 
 1.5. Classification of SPV and GPV 
GPV and SPV classified by the International Committee of Taxonomy of Viruses 
(ICTV) as belong to the genus Capripoxvirus, classified in the subfamily 
Chordopoxvirinae of the Poxviridae family (Matthews, 1982) (Table 2). According to 
records of Office Internationale des Epizootic (OIE), sheep and goatpox are classified as 
list (A) infectious diseases, which requires notification, restriction of animal movement 
and vaccination. 
 Table 1: Taxonomic Structure of the Family Poxviridae 
Subfamily Genus Index number 
Chordopoxvirinae  
 
 
 
 
 
 
Entomopoxvirinae  
 
Orthopoxvirus 
Parapoxvirus 
Avipoxvirus 
Capripoxvirus 
Leporipoxvirus 
Suipoxvirus 
Molluscipoxvirus 
Yatapoxvirus             
A.Entomopoxvirus 
B.Entomopoxvirus  
C.Entomopoxvirus  
  
00.058.1.01. 
00.058.1.02.  
00.058.1.03.  
00.058.1.04.  
00.058.1.05.  
00.058.1.06.  
00.058.1.07. 
00.058.1.08. 
00.058.2.01. 
00.058.2.02.  
00.058.2.03.   
 
 
 
 
 
 
 
 
1.6. Physiochemical properties of SPV and GPV 
The virions are brick-shaped, enveloped with rounded ends and of complex 
symmetry (Dales and Pogo, 1981). The genome is a double stranded DNA of 73–91 
MDa, with a central, less variable region of about 145 kilobase pairs and more variable 
termini with cross-links. There is extensive DNA cross-hybridization between species 
(Black et al., 1986; Gershon et al., 1989a; Murphy et al., 1995). The virion is about 300 
X 270 X 200 nm in size and resembles other viruses of the orthopox group. Two types of 
particles are observed in negatively stained preparations, namely the mulberry or ‘m’ 
form, which is electron-transparent, and the electron-dense capsule or ‘e’ form (Kitching 
and Smale, 1986). The poxviruses are generally resistant to drying, survive freezing and 
thawing, and remain viable for months in the lyophilized state. Sensitivity to heat differs 
among strains.  
The Iranian and Egyptian strains of GPV are more resistant than the Dushmbe 
strain as heating at 56°C for 1 h fails to reduce their titer significantly (Tantawi and Al-
Falluji, 1979), whereas the Sambalpur isolate of GPV is inactivated within 30 min at 
60°C (Sharma et al., 1988a). Moreover, the thermal inactivation of a Turkish strain of 
SPV leads to the loss of infectivity when it is heated to 55°C for 1 h (Koylu and 
Nitzschke, 1968). In contrast, the infectivity of the Jaipur isolate follows a bimodal curve, 
with residual infectivity titratable even after 1 h at 50°C (Pandey and Singh, 1970). The 
infectivity is sensitive to ether and chloroform (Murphy et al., 1995) but a few strains are 
resistant to ether (Bennet et al., 1944). Replication of viruses is inhibited by actinomycin 
D and bromodeoxyuridine (Tantawi and Al-Falluji, 1979). 
 
1.7. Epidemiology and transmission  
The diseases (GPV, SPV) are endemic in southwest Asia, the Middle East and 
most parts of the Indian subcontinent (Carn, 1993). The virus commonly enters through 
the host’s respiratory tract, and therefore transmission of disease frequently occurs via an 
aerosol during direct or close contact between infected and susceptible animals. 
Transmission also occurs by skin abrasion or mechanically by the action of 
insects. The disease may be transmitted by Stomoxys calcitrans and the tsetse fly (Webbs 
et al., 1980). Experimentally, the diseases can be transmitted by intradermal, intravenous 
and subcutaneous inoculation, and by artificially produced virus aerosols. Under natural 
conditions, GPV and SPV are highly host-specific but the host specificity varies from 
isolate to isolate. Kenyan and Yemen isolates and an Oman sheep isolate infect sheep and 
goats equally readily. However, isolates from the Middle East and India are host-
specific—GPV does not infect sheep and SPV does not infect goats (Bakos and Brag, 
1957; Kitching, 1983; Soman et al., 1985).  
It is believed that the virulence of capripoxviruses is so variable that some strains 
are pathogenic in goats only, and thus are considered goatpoxviruses. Other strains are 
pathogenic in sheep only, and thus are considered sheeppoxviruses. The remaining strains 
can produce disease in both sheep and goats. The host preference shown by the different 
strains is probably due to their adaptation to either sheep or goats in a restricted 
geographical area (Kitching and Taylor, 1985). Therefore, it is arguable that the 
malignant pox diseases of sheep and goats should be designated by the single term 
‘capripox’, as proposed earlier (Black, 1986). 
 Goatpox and sheeppox affect goats and sheep of all ages, both sexes and all 
breeds, but are more common and more severe in young and old animals and in lactating 
females. In a susceptible flock, morbidity is 75–100% and mortality 10–58% depending 
on the virulence of the isolate. The virus is present in the vesicular fluid, scab and milk of 
infected goats and sheep, and blood and spleen emulsions are also infective. Human 
infections during the handling of infected animals are rarely seen (Rao and 
Bandyopadhyay. 2000). 
 
1.8. Zoonosis of Capripoxvirus 
Mild lesions of small red papules followed by vesicles on the hands and arms 
have been reported in humans working with Capripoxvirus in Sweden and India. No 
generalization occurred. These are isolated incidents and humans are generally regarded 
as been non susceptible. No pathogenicity for humans has been recorded for most 
sheeppox strains (Ausvet plan, 1996).  
 
 
  
1.9. Pathogenesis 
Following intradermal inoculation, SPV and GPV, replicates locally in the tissue 
(Plowright et at., 1959). Peak virus titer in the skin was attained on day 7, when pox 
lesions were detected. The virus spreads to the regional lymph nodes before invading the 
blood stream to produce primary viremia after 3-4 days (Singh et al., 1979). Internal 
organs such as spleen, liver and lungs are affected after viremia; lung lesions, however, 
may also develop directly from inhaled virus. The peak virus titers in skin nodules persist 
from day 7 to 14 and decline thereafter, concomitantly with the development of serum 
antibodies. Excretion of SPV and GPV from sheep and goats is not documented; most 
likely skin scabs are the main source of the virus shedding, but also ocular and nasal 
secretions might be infectious (Merza and Mushi, 1990). 
 
1.10. Clinical signs  
Goat pox is clinically similar to sheep pox (Kitching and Taylor, 1985). In natural 
cases, the diseases have an incubation period of 1–2 weeks. Thereafter, the animal starts 
showing pyrexia, labored breathing, depression and loss of appetite. Body temperature 
may rise as high as 108°F. Cutaneous lesions develop after 1 or 2 days, and they progress 
through the macular, papular, vesicular and pustular stages until scabs are formed.  
 
 1.11. Pathology 
   The lesions are distributed over the hairless parts of the skin and mammary 
glands, and on the mucous membranes of the digestive and respiratory tracts. The animal 
may recover in 3–4 weeks, with permanent depressed scars. Scabs that have been shed by 
the animals remain infective for several months.  
  Generalization of the disease is often noticed in kids and lambs aged 4–5 
months, whereas in older animals mild infections are seen. In sucking animals the disease 
is more severe, with lesions on the buccal mucosa and in the anterior nares with 
mucopurulent and lachrymal discharges. Pneumonia, enlargement of the udder and 
abortion may occur in severe cases. Ulcers are also seen on the tongue and gums. Such 
lesions constitute an important means of virus dissemination.  
  Post-mortem lesions include tracheal congestion, lentil-sized, bullet-shaped 
nodules and white patches on the lungs, an inflamed spleen and lymph nodes with 
graying white necrotic lesions, and an increased quantity of blood-tinged pleural fluid. In 
some animals, lesions develop in the lungs as multiple consolidated areas.   
   Microscopically, the affected lung tissue is characterized by congestion, red 
hepatization and exudation, coagulative necrosis surrounded by a marked zone of 
inflammatory reaction, and thickening of the interlobular septae. Depletion of the 
lymphocyte population in the paracortical regions and absence of germinal centers in the 
spleen and lymph nodes are also observed (Buller and Palumbo, 1991; Saha et al., 1991). 
 
1.12. Replication of poxvirus 
The poxviruses replicate entirely in the cytoplasm. The assembly of progeny 
virions is located in specific cytoplasmic places called viroplasm or viral factories, which 
can be separated from other cellular structures in the form of virosomes. The cytoplasmic 
mode of replication implies that the machinery necessary for RNA synthesis and 
modification has to be carried by the incoming particles in order for the early viral genes 
to be expressed.  
Consequently among the active enzymes found in proteins included in the capsid, 
there are an RNA polymerase, capping and methylating enzymes, and a ploy A 
polymerase. These enzymes upon uncoating of the virus, start the transcription of a series 
of early genes, among which are those responsible for DNA synthesis, such as DNA 
polymerase, ligase, thymedine kinase and thymedine sythatase. Once the DNA synthesis 
has taken place, the mode of transcription changes to a discontinuous one to transcribe 
the so-called late genes (e.g. structural genes). 
 The life cycle is divided into several steps. Penetration and uncoating (30 min), 
early transcription (1-2 hr), DNA synthesis (2-4 hr), late transcription and assembly (4-6 
hr), and release (budding) of the virions. During the late transcription period many early 
genes cease to be transcripted. 
 It is during this phase of the life cycle that the structural viral proteins are 
expressed. An early effect of poxvirus infection on the host cell is the inhibition of 
cellular protein and DNA synthesis (Talavera and Rodriguez, 1991b). 
1.13. Isolation of Capripoxvirus   
Capripoxvirus isolation is a lengthy procedure due to slow growth of the virus in 
cell culture, in which cytopathic effects may take up to 10 days to develop (Plowright and 
Ferris, 1958).  
Material for virus isolation and antigen detection should be collected by biopsy or 
at post-mortem from skin papules, Lung lesions or lymphnodes. Samples for virus 
isolation and antigen -detection enzyme- linked immunosorbant assay (ELISA) should be 
collected within the first week of the occurrence of clinical signs, before the development 
of neutralizing antibodies.  
Samples for genome detection by polymerase chain reaction (PCR) may be 
collected when neutralizing antibody is present. Buffy coat from blood collected into 
heparin or EDTA (ethylene diamine tetracitic acid) during the viraemic stage of Capri 
pox (before generalization of lesions or within 4 days of generalization), can also be used 
for virus isolation. Samples for histopathology should include tissues from the 
surrounding area and should be placed immediately following collection into ten times 
the sample volume of 10% formalin. 
 
1.14. Virus purification and characterization 
Capripoxviruses are purified by different methods, sucrose gradient (440-60%) 
and potassium tartrate gradient (density range 1.05-1.35 g/ml) centrifugation of partially 
purified virus through a sucrose gradient (36%) (Kitching et al., 1986b). Viruses of scab 
origin are purified in a similar fashion (Rao et al., 1997a).  
The main structural polypeptides of Capripoxviruses are identical on analysis by 
polyacrylamide gel electrophoresis (PAGE), and more than 20 polypeptide bands can be 
distinguished in a purified virus preparation (Kitching et al., 1986b). The molecular 
weight of the polypeptides ranges from 14 to 130 kDa, but only a few of them are 
immunogenic (Roy. 1994; Jaikumer et al., 1996). The major common precipitating 
antigen, of about 67 kDa, induces serum-neutralizing antibodies (Singh and Rai. 1991b).  
Immunization with poxviruses evokes both humeral and cell-mediated immune 
responses (Pandey et al., 1969; Negi et al., 1988). The relative importance of circulating 
antibodies and cytotoxic T lymphocytes in the suppression of the infection is not fully 
understood. However it is quite clear that infection subsides in the host with the 
appearance of circulating antiviral antibodies (Cho and Wenner, 1973). The serum of the 
immune host contains a spectrum of antibodies reactive with virus-induced antigen (Ved 
et al,. 1969; Weinraub and Dales, 1974). 
 
1.15. Propagation and cultivation of SPV and GPV 
Natural hosts are used successfully for cultivation of the Capripoxviruses. Growth 
of the virus in heterologous hosts, i.e. GPV in sheep and SPV in goats, is achieved with 
varying success. The viruses do not grow in any species of laboratory animal. The reports 
of cultivation of SPV in embryonating chick eggs are conflicting. Ortitenz and Teicco 
(1954), Abdulla Khan (1960), Sharma et al. (1966), Adlakha et al. (1971), Onar (1971-
72), Sen and Uppal (1972), Sharma and Dhanda (1972) and Bhatnager and Gupta (1974) 
failed to propagate SPV in chick embryos. Gins and Kunert (1937) and Aygun (1955), 
however, observed oedema, leucocytic infiltration and necrosis in the infected CAM. Rao 
(1938), in addition, reported cytoplasmic inclusions in the ectoderm of the CAM. Sabban 
(1957), adapted a virulent strain of SPV (Cairo strain) on the CAM of 12 days chick 
embryos. No loss of virulence of sheep was observed after 21 alternate passages through 
eggs and sheep. A Roumanian strain of SPV could not be adapted to embryonating chick 
eggs. Yuan et al. (1957) reported attenuation of SPV after 90 successive passages on the 
CAM and used it as vaccine. Likhachev et al. (1961), stated that the chick embryo 
adapted Chinese strain was harmless for sheep and induced strong immunity at a dose of 
0.2 ml intradermally or 0.5 ml subcutaneously. Borisovich (1962) and Borisovich et al. 
(1966) reported that this chick embryo adapted ́K ̀ strain was strongly immunogenic. Arik 
and Kurtal (1974) successfully passaged SPV on CAM 25 times without any change in 
viral characteristics. GPV isolates differ significantly in their growth behavior in 
embryonated chick eggs (Adlakha et al., 1971; Tantawi and Al-Falluji, 1979). Iranian, 
Kenyan and Indian strains grow well on chorioallantoic membranes (Joshi et al., 1996), 
whereas Russian strains do not. The Iranian Gorgon strain and Egyptian strains grow 
poorly on chorioallantoic membranes. 
SPV produces CPE in various cell culture systems. Edlinger and Iftimovici (1973) 
in their studies on SPV in lamb kidney and testicle cell cultures found that the CPE was 
non-specific and consisted of diffused areas of rounded cells without plaque formation 
and no detachment of the cell layer. Mateva and Stoichev (1975) also could not find any 
characteristic CPE with SPV in LT cells. Studies on the replication of SPV in LT cells 
have shown that most of the progeny virus remained intracellular, as only approximately 
3% of the total yield was released into the medium, the rest of the virus remaining cell-
associated (Srivastava 1975). GPV and SPV are adapted to and are able to grow in a 
number of host systems in vitro, most of which are derived from sheep, goats and cattle. 
Of these, lamb testis (LT) cells and sheep or goat kidney cells are very sensitive systems 
in which the viruses produce characteristic cytopathic effects, such as rounding, tract 
formation, retraction and ballooning of cells, nuclear vacuolation, chromatin 
fragmentation, loss of continuity of the cell sheet, and intracytoplasmic inclusion bodies 
(Adlakha et al., 1971; Joshi et al., 1994). Other cell culture systems, e.g. sheep thyroid 
cell monolayers and embryonic goat cell culture, are also quite sensitive. Some isolates 
will grow in bovine fetal muscle cells and calf kidney cells (Davies and Mbugwa, 1985).  
The viruses (SPV, GPV) can also be grown in some established cell lines. GPV 
will grow in the Vero (Ved Prakash et al., 1994) and MDBK cell lines (Joshi et al., 
1995). Similarly, most SPV isolates will grow in MDBK (Pandey et al., 1985) and Vero 
(Singh and Rai, 1991a) as well as BHK21 cells (Kirubaharan et al., 1993). 
 
1.16. Soluble antigens 
Cragie (1932) used the term ‘filterable precipitable substances’ to describe the 
material present in virus-free extracts of vaccinia-infected tissues that reacted with anti-
vaccinia sera. Since then, the term ‘soluble antigen’ has been applied to virus-free, 
serologically reactive extracts obtained from virus-infected tissues after the viral particles 
have been pelleted by high-speed centrifugation (Anthony et al., 1971).  
These antigens, which are released or are separable from the infectious virions, 
are presumed to represent structural subunits of the virus and virus-induced enzymes. 
Furthermore, immunological analysis of preparations of soluble antigens of capripoxvirus 
reveals a number of immunoprecipitinogens. Hence, soluble antigen is considered a 
valuable diagnostic tool. Soluble antigens are abundantly available in the scab lesions of 
poxviruses compared with infected cell cultures.  
A soluble antigen fraction is obtained by high-speed centrifugation of clarified 
scab suspensions (Rao et al., 1996a). The clear supernatant is saved and concentrated, if 
necessary, by reverse dialysis with polyethylene glycol. The soluble antigens are also 
extracted by treating the crude antigen with fluorocarbon followed by centrifugation 
(Pandey and Singh, 1972; Isloor and Negi, 1995). All the methods use centrifugation to 
precipitate the virus particles physically, leaving the soluble antigens in the supernatant 
fluid; this fluid can be stored indefinitely at –20°C in small aliquots. Soluble antigens are 
necessarily virus-induced antigens that are produced perhaps in excess quantities during 
viral replication. The antisera raised against them can neutralize the infectivity of the 
virus effectively because some of the soluble antigens are structural components of the 
virus (Sambyal and Singh, 1978; Tiwari and Negi, 1994; Rao et al., 1997a).  
The soluble antigens of GPV or SPV also contain a major polypeptide of about 67 
kDa, which may be similar to that found in the intact virion. These properties, together 
with its noninfectious nature, make the soluble antigen fraction an important diagnostic 
tool for poxvirus diseases. The soluble antigens differ markedly in their molecular 
weight, with five to seven precipitinogens detectable.  
Among the soluble GPV antigens, at least one precipitinogen is stable at boiling 
temperature for 10 min, and another is resistant to trypsin. Ether and chloroform have no 
effect on the immunoprecipitation pattern of the soluble GPV antigens (Isloor and Negi, 
1995). The soluble SPV antigens show a varied electrophoretic mobility, with sharing of 
antigenic determinants among a few proteins (Rao et al., 1997a).  
Moreover, their physicochemical properties differ slightly from those of GPV, as 
all the soluble SPV antigens are sensitive to trypsin and ether as well as to boiling 
temperature. Chloroform, however, has no effect on their immunoprecipitation pattern. 
 
1.17. Antigenic relationship  
Capripoxviruses are antigenically related, and GPV and SPV share one or more 
precipitin band depending upon the antiserum used (Sharma and Dhanda, 1969; Subbarao 
et al., 1984). The viruses cross-react in the complement fixation test (Sharma and 
Dhanda, 1971). The sharing of antigens between the viruses can be further demonstrated 
by ELISA, sodium dodecyl sulfate–polyacrylamide gel electrophoresis, the leukocyte 
migration inhibition test, immunoelectrofocusing (IEF) and IEF-gel blotting.  
The techniques of IEF, IEF-gel blotting and dot-immunobinding are useful in the 
differential diagnosis of goat pox and sheep pox (Indian Veterinary Research Institute, 
1986; Datta and Soman, 1990). Though the major portion of the antigens of GPV and 
SPV are similar, there may be some differentiating antigenic components in each virus 
(Rao et al., 1996b). 
Moreover, within isolates or strains of SPV (and possibly GPV), the antigenic 
make-up is largely similar (Bhat, 1993) but may not be identical (Puranchand et al., 
1987). Furthermore, it seems that neither GPV nor SPV is serologically related to 
contagious pustular dermatitis virus, a parapoxvirus (Rao et al., 1999; Ngichabe et al., 
1999); however, the results of cross-reactions often vary, which is probably due to the 
different methods used by different workers employing different isolates of capripoxvirus 
(Sharma and Dhanda, 1971; Subbarao et al., 1984; Kitching et al., 1986b). 
  
1.18. Diagnostic tests 
Pox diseases are usually identified according to their clinical signs and gross 
pathology and the host species affected. The infections caused by GPV and SPV cannot 
be distinguished either serologically or on the basis of the clinical signs as the viruses are 
very closely related. 
 It appears that the host preference shown by these viruses with respect to either 
sheep or goats, accompanied by the case history, may be regarded as partially affirmative 
for either sheeppox or goatpox, but accurate identification requires laboratory studies. It 
is also known that homologous diagnostic reagents tend to be more efficient than 
heterologous reagents in the accurate diagnosis of these diseases (Pandey and Singh, 
1972). 
 Therefore, separate diagnostic procedures have evolved for the diseases. The 
non-infectious soluble antigen fraction alone can efficiently replace the use of infected 
scab suspensions or infectious virus, which pose a considerable disease security problem 
as the virus is highly infectious (Rao and Negi, 1997; Rao et al., 1997b; Singh et al., 
1998).  
In addition, the diagnosis of goatpox and sheeppox by classical virological or 
serological techniques that depend on live viruses is not suitable in countries where the 
viruses are exotic and live viruses are not available. There is an extremely useful 
diagnostic method based on the polymerase chain reaction (PCR) for the detection of the 
viral nucleic acid of GPV and SPV in those countries that are free of these viruses. 
 Besides animal inoculation tests in natural hosts, the following tests can be 
employed routinely for the diagnosis of goatpox and sheeppox in field samples. 
 
1.18.1. Serological diagnosis  
1.18.1.1. Virus neutralization  
A test serum can either be titrated against a constant titre of Capri poxvirus (100 
TCID50 [50% tissue culture infective dose]) or a standard virus strain can be titrated 
against a constant dilution of test serum in order to calculate a neutralization index 
(Kitching and Carn, 1996). Because of the variable sensitivity of cell culture to 
Capripoxvirus, and to consequent difficulty of ensuring the use of 100TCID50, the 
neutralization index is the prefered method. The test is described using 96-well flat-
bottomed tissue-culture grade microtitre plates, but it can be performed equally well in 
tissue culture tubes with the appropriate changes to the volumes used, although it is more 
difficult to read an end-point in tubes. The used of Vero cells in the virus neutralization 
test has been reported to give more consistent results (OIE Manual, 2004).   
 
1.18.1.2. Agar gel precipitation test (AGID) 
A gel diffusion technique for the diagnosis of sheeppox and goatpox was 
introduced as early as the 1960s, using either homologous (Bhambani and 
Krishnamurthy, 1963) or heterologous (Uppal and Nilakantan, 1967) antiserum. 
Currently, a more efficient agar gel precipitation test (AGPT) using better diagnostic 
reagents, such as the soluble antigens, is available (Rao and Negi, 1997; Rao et al., 
1997b). In addition, the use of [35S]methioninelabeled antigen preparations considerably 
improves the sensitivity of the AGPT in the detection of capripoxvirus antibody 
(Kitching et al., 1986b). 
 
1.18.1.3. Counter-immunoelectrophoresis (CIE) 
Immuno-electroprecipitation is commonly used for the detection of various 
antigens and antibodies. The counter-immunoelectrophoresis test (CIE) test is more 
sensitive and rapid than the AGPT in the diagnosis of goatpox (Sharma et al., 1988a). 
Normal saline solution may be used as an alternative to barbitone buffer to carry out the 
CIE test to make it more efficient (Rao et al., 1999). The test can also detect antigens in 
organs of sheep infected with sheeppoxvirus (Puranchand et al., 1985), and it is also used 
for the rapid diagnosis of sheeppox (Rao et al., 1997b). 
 
1.18.1.4. Latex agglutination test 
Latex beads provide a convenient carrier for antigens in agglutination tests, and 
coating the beads with antigen is not difficult (Hudson and Hay, 1989). Latex 
agglutination assays have been used successfully in the detection of various antigen–
antibody systems and have proved to be rapid and simple to perform, and they need no 
expensive equipment. The test is more efficient than the CIE test in the diagnosis of 
goatpox in field samples (Rao et al., 1996a) and can also be used to diagnose sheeppox 
(Rao et al., 1997c). 
 
1.18.1.5. Reverse-phase passive hemagglutination test 
Capripoxviruses are non-hemagglutinating (Matthews, 1982). Therefore, an 
indirect hemagglutination test, such as the reverse-phase passive hemagglutination test 
using sensitized sheep erythrocytes, is useful in the laboratory diagnosis of goatpox and is 
more sensitive than the AGPT and the CIE test. Among the various types of sensitized 
sheep erythrocytes, glutaraldehyde- and tannic acid-treated erythrocytes give the best 
results for the diagnosis of goatpox and sheeppox (Rao and Negi, 1997; Rao et al., 
1997b). Several agglutination tests, viz. coagglutination (Joshi et al., 1989), passive 
hemagglutination (Joshi et al., 1991) and spot agglutination (Tiwari et al., 1996), are also 
available for the simple and rapid diagnosis of goatpox. Though all the hemagglutination 
tests consist basically of an indirect hemagglutination test that has been modified slightly, 
the coagglutination test is based on the _-globulin-binding ability of protein A, which is 
found frequently on the cell wall of certain strains of Staphylococcus aureus. 
1.18.1.6. Indirect fluorescent antibody test  
Capripoxvirus-infected cell culture grown on flying cover-slips or cell culture 
microscope slides can be used for the indirect fluorescent antibody test. Uninfected cell 
culture control, and positive and negative control sera, should be included in the test. 
 The infected and control cultures are fixed in acetone at -20ºC for 10 minutes and 
stored at 4°C. Dilutions of test sera are made in PBS, staring at1/5, and positives are 
identified using an anti-sheep gamma-globulin conjugated with fluoroscein thiocyanate 
(Davies and Atema, 1978). Cross reaction can occur with Orf, bovine popular stomatitis 
virus and perhaps other poxviruses. 
 
1.18.1.7. Western blot analysis 
Western blotting of test sera against Capripoxvirus-infected cell lysate provides a 
sensitive and specific system for the detection of antibody to Capripox structural proteins, 
although the test is expensive and difficult to carry out (Chand and Black, 1994). 
 
1.18.1.8. Single radial hemolysis test 
This test depends on the fact that complement lyses erythrocytes when antigen–
antibody complexes use it. The test gives a simple and quantitative estimate of antigen 
and antibody and is used successfully to diagnose goatpox and sheeppox (Rao and 
Chandra, 1986; Tiwari and Negi, 1996a). 
 
1.18.1.9. Enzyme-linked immunosorbent assay 
The enzyme-linked immunosorbent assay (ELISA) is now used widely to detect 
antibodies and antigens in a variety of test systems, and is more sensitive than virus -
neutralization tests (Carn et al., 1994a). Various methods of ELISA are available to 
diagnose goatpox and sheeppox, but problems such as a considerable background 
reaction (Sharma et al., 1988b) and the requirement for special reagents, such as 
recombinant proteins (Carn, 1995), often limit their use as routine screening tests. 
Hence, an immunocapture ELISA has been developed as a relatively simple assay 
for the detection of GPV and SPV antigens in scab suspensions (Rao et al., 1997d). 
 However, this assay also has a limitation in that it is best used only in 
combination with the CIE test for accurate and confirmative diagnosis.  
A dot ELISA, carried out on nitrocellulose strips or paper, is a valuable addition 
to the battery of diagnostic methods for goatpox and is about three times more sensitive 
than the single radial hemolysis test (Tiwari and Negi, 1996b). Recently, an avidin–biotin 
ELISA was introduced for the detection of antibodies to GPV in goat sera; it uses an 
isolated fraction of the soluble antigens that substantially reduces the background 
reaction in the assay (Rao et al., 1999).  
This assay is a reliable test for capripoxvirus antibody that may be used to assess 
immunity to goatpox and possibly sheeppox, and can also be used in epidemiological 
studies. 
 
1.18.2. Molecular Methods 
There have been few studies of the molecular biology of GPV and SPV. 
Restriction analysis of genomes of the viruses isolated from different countries revealed 
that sheeppox and goatpox are caused by very closely related isolates of capripoxvirus 
(Black, 1986). Such analyses not only demonstrated the genetic relatedness (Black et al., 
1986; Bhat et al. 1993) but were also used as molecular epidemiological tools for the 
characterization of the viral genomes of capripoxviruses (Bhat and Mishra, 1989).  
The extent of nucleotide divergence values within the genomes suggest that the 
typical sheep and cattle isolates are more closely related to each other than to goat 
isolates (Gershon and Black, 1988).  
There is, however, less divergence between Capripoxvirus genomes than that seen 
in orthopoxvirus genomes (Gershon et al., 1989b). Furthermore, the Capripoxviruses can 
be used successfully as viral vectors in the preparation of recombinant vaccines by 
incorporating foreign viral genes, such as those of the rinderpest and bluetongue viruses 
(Romero et al., 1993; Wade-Evans et al., 1996). 
 
 
 
 
1.18.2.1. Polymerase chain reaction (PCR) 
PCR was discovered by kary B. Mullis in 1983 (Mullis, 1990). PCR can be 
defined as an invitro (cell free) method for enzymatic synthesis of specific DNA 
sequences using two oligonucleotide primers that hybridize to opposite strands and flank 
the region of interest in the target DNA. Repetive cycles involving template denaturation, 
primers annealing and the extension of annealed primers by DNA polymerase results in 
the exponential accumulation of specific fragment whose termini are defined by 5´ends of 
the primers (Reubel and studdert, 1998) 
Although they are sensitive, methods such as ELISA and virus isolation in cell 
culture fail to detect virus particles that are bound to neutralizing antibody (Ireland and 
Binepal, 1998), and the sensitivity of precipitation and agglutination tests is relatively 
low. Hence, highly sensitive molecular biological techniques based on the PCR are now 
employed for the identification of many viruses, including GPV and SPV in skin biopsies 
and cell cultures (Ireland and Binepal, 1998; Heine et al., 1999; Mangana-Vougiouka et 
al., 1999; Parthiban et al., 2005).  
The oligonucleotide primer pairs used for PCR amplification of genomes of either 
GPV or SPV are listed in Table 1. PCR-based diagnostic methods are exceptionally 
effective for the diagnosis of goatpox and sheeppox in suspected skin samples obtained 
from the field (Rao et al., 2001).  
However, differential diagnosis of goat pox and sheep pox based solely on the 
PCR technique is not yet feasible, but may be possible by restriction analysis of PCR-
amplified products.  
Sheep and goatpox should be differentiated from: Bluetongue, peste des petits 
ruminants, contagious ecthyma, photosensitization, dermatophilosis, insect bites, parasitic 
pneumonia, caseous lymphadenitis and mange (scrabies) (OIE Manual 2004). 
 
1.19. Clinical management 
All infected sheep or goats should be placed in a clean, well-ventilated enclosure 
and fed a balanced diet at a high level. Animals reluctant to feed should be given 10% 
glucose saline parenterally. All diseased animals should be treated with antibiotic to 
restrict secondary bacterial infections.  
To relieve respiratory-related signs, the nostrils should be cleaned and washed 
with a weak solution of potassium permanganate (1:10 000). Respiration should be 
stimulated with eucalyptus oil inhalations or coramine. Antibiotic ointment or powder 
should be applied topically to the skin lesions (Nandi et al., 1999). 
 
1.20. Immunity of Capripoxvirus 
Maternal immunity provides protection from sheep and goatpoxvirus up to 3 
months (Kitching, 1986). Animals that have recorded from Capripoxvirus infection do 
not remain carriers of the virus and have lifelong immunity. 
 
1.21. Control of diseases (SPV, GPV) 
In Sudan, a live attenuated vaccine developed against Capripox, from strain 0240 
by serial culturing in LT cells was used to protect sheep and goats throughout the 
Capripox enzootic areas. The vaccine is stable and safe to use, and provided substantial 
protection for at least a year (Kitching et al, 1986).  In enzootic areas, both live 
attenuated and inactivated vaccines may be useful in the prevention and control of 
goatpox and sheeppox. However, the inactivated vaccines that are available for 
immunization against GPV and SPV infections give only short-term immunity (Prasad 
and Datt, 1973; Yadav et al., 1986).  
The live attenuated vaccines are highly immunogenic but their usefulness is 
limited because they stimulate a pock reaction and/or lead to the death of some of the 
vaccinated animals because of generalization of the disease. Usually, homologous 
vaccination incorporating the locally prevalent strains of GPV or SPV is successful in 
protecting goats and sheep against goatpox and sheeppox.  
Therefore, in different countries and sometimes within a country, various live 
attenuated vaccines for goatpox have been available from time to time, with varying 
degrees of protective efficacy (Ramyar et al., 1974; El-Zein et al., 1983; Davies and 
Mbugwa, 1985; Guo et al., 1986; Wang and Jiang, 1988; Mahmood et al., 1993). 
Similarly, live attenuated vaccines using different isolates of SPV serially 
passaged in various cell culture systems have been available for the control of sheeppox 
(Singh et al., 1984; Mahmood et al., 1988; Chandra et al., 1990). In India, a live 
attenuated vaccine prepared from the Romanian strain of SPV is currently used to confer 
immunity in all types of sheep against sheeppox and is quite safe and effective (Jadhav et 
al., 1989). 
Although it may not always be successful, a single vaccine prepared from a strain 
of capripoxvirus that infects sheep and goats equally can be effective in controlling both 
sheeppox and goatpox (Kitching et al., 1987). A subunit vaccine has proved effective in 
protecting goats against capripox (Carn et al., 1994b).  
On the whole, reports of cross-protection of sheep and goats against goatpox and 
sheeppox and other related diseases, such as contagious pustular dermatitis, are often 
contradictory and inconclusive because attempts to protect goats with SPV vaccines are 
usually unsuccessful (Prasad and Datt, 1973). Hence, it is recommended that homologous 
vaccines should be used to protect goats and sheep against goatpox and sheeppox. 
 
Table 2: Oligonucleotide primers for PCR amplification 
 
Primer 
pair 
Sequence (5´Æ 3´) Length 
(bp) 
PCR 
product 
size (bp) 
Virus 
detected 
Reference
1. Left 
  Right 
TTTCCTGATTTTTCTTACTAT  
AAATTATATACGTAAATAAC 
21 
20 
192 SGPV Ireland and 
Binepal, 
1998 
2. Left 
  Right  
ATGGACAGAGCTTTATCA 
TCATAGTGTTGTACTTCG 
18 
18 
472 GPV Ireland and 
Binepal, 
1998 
3. Left 
  Right 
GTCTGACTTTCCTGCCGAAT 
TCTATTTTATTTCGTATATC 
20 
20 
149 SPV Mangana-
Vougiouka et 
al., 1999 
4. Left 
  Right 
AGAAACGAGGTCTCGAAGCA 
GGAGGTTGCTGGAAATGTGT 
20 
20 
289 SPV Mangana-
Vougiouka et 
al., 1999 
5. Left 
 
 Right 
CTAAAATTAGAGAGCTATACT
TCTT 
CGATTTCCATAAACTAAAGTG
25 
 
21 
390 SPV Heine et al., 
1999 
 
 CHAPTER II 
MATERIALS AND METHODS 
2. Field work 
2.1. Sheep and goatpox outbreaks 
 Two outbreaks of sheeppox that occurred in June 2003 in Gedarif State, east of 
the Sudan were investigated. The first outbreak occurred at Shott, east river Atbara and 
the second outbreak occurred at Abu Garra, south of Showak city. No infections in goats 
were recorded. Another outbreak of goutpox occurred at Hillat Kuku in Khartoum State, 
in March 2005. The disease affected Saanen goats imported from Holland and raised for 
breeding by Ministry of Animal Resources (MAR). These goats were previously 
vaccinated against sheep and goatpox with 0240 vaccine strain. 
 During each investigation the total number of animals at risk, number affected, 
number dead as well as other species of animals affected were recorded. Clinical signs 
and course of the disease were noted. Table 3 shows total number of animals at risk and 
epidemiology of sheep and goatpox infections in Gedarif and Khartoum states.  
 
2.2. Collection of samples  
 Two samples of skin scabs (SP1O) from Shott region and skin nodule (SP2) from 
Abu Garra region were collected from sick sheep. Two samples of skin scabs (GP1 and 
GP2) were collected from sick goats (Saanen breed). These samples were collected into 
50% buffered –glycerol solution (Appendix 6.1) and stored at + o4 C until brought to 
Virology Research Laboratory, Department of Microbiology, Faculty of Veterinary 
Medicine, University of Khartoum on ice.  
 
2.3. Laboratory work 
 2.3.1. Viruses 
2.3.1.1. Laboratory strains of sheeppox 
 Sheeppox isolate (SP4) obtained from the virus stock of Virology Research 
Laboratory Department of Microbiology, Faculty of Veterinary Medicine, University of 
Khartoum, SP4 was isolated in LT cell culture from skin scabs collected from sick sheep 
in an outbreak that occurred at Gezira State in 1997. 
 
2.3.1.2. Lumpy skin disease virus (LSD) 
This strain of LSD was isolated from cattle during an outbreak of the disease that 
occurred in Gezira State in June 2003 (Khalafalla, unpubished data). 
 
2.3.1.3. Virus samples for Kenya sheep and goatpox vaccine strain 0240 
Samples of the vaccine strain 0240 were obtained from the vaccines seed bank, at 
the viral vaccines production unit of the Central Veterinary Research Laboratories 
(CVRL), Khartoum, Sudan. 
 
2.3.1.4. Hyper immune serum 
This was obtained from the vaccines seed bank, at the Viral Vaccines Production 
Unit of the Central Veterinary Research Laboratories (CVRL), Khartoum, Sudan. 
 
2.3.2. Preparation and sterilization of glassware 
Glassware like flasks, beakers and measuring cylinders were rinsed in running tap 
water, brushed with special tissue culture flasks soap, and left overnight in 1% HCL. 
They were then washed thoroughly by rinsing several times in tap and distilled water. 
After that, they were wrapped with aluminum foil and sterilized in hot air oven at 160 ˚C 
for 2 hours. The volumetric pipettes were left overnight in 3% HCL. Then they were 
washed thoroughly by rinsing several times in tap and distilled water. The clean dry 
pipettes were cotton plugged, placed in canisters and sterilized in hot air oven at 160 ˚C 
for 1 hour. 
 
2.3.3. Preparation and sterilization of plastic wares  
 Rubber liners for bottles and plastic cylinders were cleaned with detergent, 
washed with tap water followed by distilled water, left to dry and sterilized by 
autoclaving at 121˚C for 15 minutes. 
 
2.3.4. Preparation and sterilization of filters and papers 
Millipore filters (0.22µ) were assembled in their appropriate holders, wrapped in 
aluminum foil and sterilized by autoclaving at 121˚C for 15 minutes. 
 
2.4. Virus isolation 
2.4.1. Preparation of samples 
Skin specimens were homogenized using sterile mortars and pestles with the aid 
of sterile sand and physiological saline (PS) (Appendix 1.1). 20% suspensions were made 
and then centrifuged at 1000 rpm for 10 minutes. Supernatant fluids were collected into 
sterile bottles and treated with antibiotics (1000 IU penicillin- 250 mg of streptomycin 
(Appendix 9.5.1) and 5.000 IU of mycostatin (Appendix 9.5.4). The supernatant fluids 
were left for ½ -1 hour at 4˚C and then stored at -20˚C till used. In vesicle swabs samples 
2ml of medium, Glassgow Modified Eagle,s Medium (GMEM) with antibiotics, were 
added,  mixed and left overnight at 4˚C, then centrifuged at 1000 rpm for 10 minutes and 
supernatant fluids were collected. 
 
2.4.2. Fertile eggs 
Nine to eleven days-old chicken eggs were obtained from the poultry farm of 
department of Microbiology, Faculty of Veterinary medicine, University of Khartoum. 
The eggs were candled for viability and then the shell surface was cleaned by immersing 
in alcohol for 5 minutes or by swabbing with tincture of iodine. The eggs were used to 
grow the virus on the chorioallantoic membrane (CAM).  
 
2.4.3. Inoculation of the chorioallantoic membrane (CAM)  
A hole was made through the shell of the air sac by the pointed punch and another 
hole on the top of the egg just to penetrate the shell and shell membrane. The dropping of 
the membrane was verified in dark room by candling, and then a rubber bulb was placed 
over the hole in the air sac to slowly aspirate air from the sac by releasing pressure on the 
deflated bulb. The suction caused false air sac in the area of the second hole. To deliver 
the inoculum on the chorioallantoic membrane (CAM), the tip of one ml needle was 
inserted just within the shell and 0.2ml was inoculated into embryonated eggs. Four 
samples (SP1O, SP4, and GP1) and vaccine strain 0240 were inoculated on CAM. The 
inoculated eggs were incubated at 37˚C, and were examined daily for 5 days. 
 
2.4.4. Harvest of the chorioallantoic membrane (CAM) 
After 5 days incubation the shell was disinfected on the small end of the egg by 
70% alcohol, and the end of the egg was cracked off by sterile forceps. The CAM was 
removed from the shell by sterile forceps .The CAM was placed in a petri dish and 
examined for pock lesion formation and or any other lesions. 
 
2.4.5. Preparation of cell culture 
2.4.5.1. Primary lamb testis cell culture (LT) 
Primary lamb testis (LT) cell cultures were prepared from prepubertal lamb as 
described by Plowright and Ferris (1958). The testis were aseptically removed from 2-6 
weeks old lamb immediately after slaughter and placed in sterile Petri dishes and all 
tunica vaginalis, epididymes and testicular bursa were removed. Testis were then 
transferred to other Petri dishes then fragmented with scissors into small pieces.  The 
tissue fragments were then transferred to a trypsinization flask containing a magnetic bar 
and washed several times with PD till the supernatant fluid become clear. A freshly 
prepared prewarmed 0.25% trypsin in HPSS (10% trypsin in Hank,s) was added to the 
washed tissue fragments in amounts sufficient to cover them. The contents were stirred 
for 30 minutes at room temperature and the supernatant fluid was discarded, fresh 
prewarmed 0.25% trypsin solution was added at a volume that was three times the 
volume of tissue fragments. The tissue fragments were then digested for 1 hour at 37˚C 
in10% trypsin in HPSS. At the end of the trypsinization period, large fragments of tissue 
were removed by filtration through sterile gauze. The dispersed cells in the filtrate were 
deposited by the centrifugation at 600 rpm for 5 minutes. 
 The cells were then washed once with PD containing 2% calf serum and 
centrifuged. The packed cells were resuspended in 10 ml of PD and vigorously pipetted. 
The cells suspension was finally diluted in growth medium and then distributed in the 
tissue culture flasks. Confluent monolayers were established within 3-5 days. 
 
2.4.5.2. African Green Monkey Kidney cell culture (Vero cell culture) 
             Confluent monolayer cell culture of Vero cell was purchased from Veterinary 
Laboratories Agency, United Kingdom. The growth medium was removed and the cell 
briefly washed with sterile PD. Three ml of trypsin and versin solutions were added and 
the bottle incubated at 37˚C until cells flew freely when the bottle was tilted. Few drops 
of calf serum were added to stop the action of trypsin and versin and the suspension was 
centrifuged at 1000 rpm for 5 minutes. The supernatant was pour out and the pelleted 
cells were resuspended in 10 ml of growth medium and mixed well by pipetting. The 
suspension was diluted in growth medium and distributed in tissue culture flasks or tubes 
and then incubated at 37˚C. 
 
2.4.5.3. Madin Darby Bovine Kidney cell lines 
Confluent monolayer of Madin Darby Bovine Kidney cell line (MDBK) was 
purchased from Veterinary Laboratories Agency (VLA), United Kingdom and was 
prepared as described for preparation of Vero cell line. 
 
2.4.5.4. Preparation of chicken embryo fibroblast (CEF) 
Embryonated chicken eggs 9-11 day old were obtained from the poultry farm of 
Department of Microbiology Faculty of Veterinary Medicine, University of Khartoum. 
Eggs were candled for viability and then the shell surface was cleaned by immersing in 
70% alcohol for 5 minutes or by swabbing with tincture iodine. Round shell just below 
the air sac was cut, the embryo lifted out. The head was cut, viscera were removed and 
the remains were fragmented with scissor into small fragments. Then the fragments were 
washed several times with PD and transferred to a trysinization flask. 
The trysinization was carried out in discontinuous manner; 5 ml of 0.25% 
prewarmed trypsin solution per embryo were added and stirred slowly for 15 minutes at 
25˚C or 37˚C. After the tissue had settled out, the supernatant cells (containing single 
cells and small clusters of cells) were collected in a container with 1-2 ml of calf serum 
and kept on ice; this was repeated 3-5 times until only the white fibrous tissue were left 
and no more cells disperse. The procedure for preparation of monolayer was similar to 
that described for lamb testis cell culture. A confluent monolayer was established within 
1-2 days. 
 
2.4.6. Virus propagation and adaptation 
Four samples (SP1O, SP2, SP4 and GP1) were inoculated into semi confluent 
lamb testis cell culture in 25cm3 tissue culture flask. Each flask received 0.5 ml of virus 
suspension and left for 1 hour at 37˚C for adsorption. Then the inoculum was removed 
and the semi confluent monolayer were washed twice with PD and refed with 
maintenance medium (GMEM) and kept at 37˚C. At day 7 post inoculation, the 
monolayer was splitted using trypsin-versin and the infected cells reseeded again. This 
procedure was repeated for 3 passages in (LT), one passage in MDBK cells and 2 
passages in Vero cell until clear CPE was seen. The cultures were harvested by freezing 
and thawing 3 times, and then centrifuged at 1000 rpm for 5 minutes. The supernatant 
was collected and labeled as stock virus. 
  
2.4.7. Cell culture spectrum  
Prepared LT cells, Vero cells, MDBK cells and CEF cells were inoculated, 
splitted, reseeded again and harvested as described for propagation and adaptation of the 
virus. 
 
2.5. Virus titration 
Determination of tissue culture infective dose 50/ml (TCID50/ml) for SPV and 
GPV was performed following the procedure described by Villegas and Purchase (1983). 
Micro plates containing 96-wells were used. Ten-fold dilution of virus (10-1_ 10-8) was 
prepared in GMEM. 100µl of each dilution was added to 5-wells then 100µl of 2X Vero 
cells suspension was added to each well. The micro plate was incubated at 37˚C and 
examined for the presence of CPE 9 days post inoculation. Titres were expressed as 
TCID50/ml calculated according to the method of Reed and Muench (1938) as described 
by Villegas and Purchase (1983). 
 
 
2.6. Virus neutralization  
The alpha neutralization procedure (constant-serum, diluted virus) as described 
by Beared (1983) was followed. In this method, micro plate containing 96-wells were 
used, 10 fold serial dilutions (10-1 - 10-8) of virus under test were prepared in GMEM and 
each 5-wells received 100µl of virus dilution. Each virus dilution was mixed with an 
equal volume of 1/5 dilution of hyper immune serum (HIS) against SPV and GPV 
(100µl). The mixtures were shaken vigorously and incubated at 37˚C for ½ hour. After 
that 100µl of Vero cells suspension were added to each well and incubated at 37˚C. The 
end point titre of each serum-virus mixture was calculated. Determination of the 
neutralization index (NI) was made by calculating the difference between the log titre of 
the virus titration and the log of HIS-virus mixture. 
 
2.7. Polymerase chain reaction (PCR) 
2.7.1. DNA extraction 
Three methods of DNA release were used. The first method of DNA extraction 
(PCR1) was the simplest method: by adding (20-15-10-5 µl) of cell culture or biopsy 
supernatant to the PCR minus the polymerase and heat the reaction at 99ºC for 15 
minutes. The second method of  DNA extraction (PCR2) was done according to Tripathy 
(2003) with phenol-chloroform extraction .2 ml of cell lysis solution (10mM Tris-
Hcl,ph7.4),100mM Nacl,10mM EDTA, 0.5% SDS, 2% β mercaptoethanol) were 
homogenized with  scabs in morter and pestle ,and then transferred to eppendorf 
tube.Then 15µl of protinase K solution (10mg/ml) was added and the sample was 
vortixed for few seconds, incubated at 55˚C for 4 hours or at 37˚C for overnight  ,then the 
sample was vortixed after every 15 minutes during incubation.10 µl of RNase were added 
and inverted 25 times, then incubated at 37˚C for 15 minutes .DNA was extracted from 
the digest in the presence of equal volumes of phenol-chloroform-isoamyalchohole 
(50:2:48).The extraction lasted for 30 second with mixing by inverting the eppendorf 
tube followed by centrifugation at 10,000 rpm for 1 minute. The tube will be divided to 
three layers, phenloic phase, interphase (protein), aqueous phase. 
The aqueous phase was removed to another eppendorf tube with phenol-
chloroform and this was repeated for three times. The last aqueous phase was transferred 
to another tube (1.5ml) and 3Mna acetate were added in a volume equivalent to 1:10 of 
aqueous phase and an equal volumes of Isopropanol alcohol was mixed and stored at -
20°C overnight. The DNA was pelleted by centrifugation at 13,000 rpm for at least 45 
minutes at +4˚C.Then the DNA pellet was washed with 300µl 70% alcohol with 
centrifugation at 13,000 rpm for 15 min at +4˚C, and the ethanol was poured off. The 
tubes were then allowed to dry for 10-15 minutes .50µl DNA hydration solution was 
added and DNA was dissolved by incubating at 65˚C for 1 hours and then the DNA was 
stored at 4°C until used. 
The third method of DNA extraction (PCR3): when 90% CPE appeared, cell 
culture in plastic flasks were harvested by freezing and thawing three times, then pelleted 
by ultracentrifugation (Suprafuge 22, fixed angle, rotors HFA 22.50, 8X50ml, Heraeus 
Sepatech), for 1hour at 20000 rpm to pellet the virus. The supernatant was discarded, the 
pellet drained, covered with 0.5 ml of PBS and kept at 4˚C overnight. The pellet was 
dissolved and transferred to an eppendorf tube (1.5ml). 
DNA was extracted by using PUREGENE® DNA isolation kit (Gentra System, 
Minneapolis, USA) with some modifications. Briefly, 300µl cell lysis solution was added 
to the cell lysate in 1.5ml micro tube, and the mixture was homogenized in a vortex. Then 
2µl of proteinase K solution (20mg/ml) were added to the lysate and the suspension was 
mixed by inverting 25 times, incubated at 55˚C overnight, followed by the addition of 
1.5µl RNase A solution (4mg/ml) to the cell lysate. The samples were then mixed by 
inverting the tube 25 times and the tubes were incubated at 37˚C for 15-60 minutes, 
cooled to room temperature and 100µl protein precipitation solution was added to the cell 
lysate. The tubes were vortexed at high speed for 20 seconds and then centrifuged at 
16.000xg for 3 minutes. Then 300µl of 100% Isopropanol was added to the supernate 
fluid into a clean 1.5 microfuge tube, mixed by inverting gently 50 times, and 
centrifuging at 16.000xg for 1 minute to pellet the DNA. The supernatant was poured off 
and the tubes were drained briefly, after that DNA was washed with 300µl of 75% 
ethanol, centrifuged at16.000xg for 1 minute and the ethanol was poured off. The tubes 
were then allowed to dry for 10-15 minutes. 50µl DNA Hydration Solution was added 
and DNA was dissolved by incubating overnight at room temperature and then stored at -
20˚C until used. 
2.7.2. Oligonucleotide Primers  
Primers were purchased as freeze dried oligonucleotides (INVITROGEN). 
Reconstituted with 1ml DDW and left overnight at 4˚C. Working solutions of each 
primer were prepared so as to contain 10Pmol/µl of oligonucleotides pair of primers of 
viral attachment protein (VAP) gene were described by Ireland and Binepal (1998), the 
VAP F sequence is (5´ to 3´) TCC GAG CTC TTT CCT GAT TTT TCT TAC TAT with 
molecular weight of 9056.0 and the sequence of VAP R is (5´ to 3´) TAT GGT ACC 
TAA ATT ATA TAC GTA AAT AAC with molecular weight 9197.0. 
  
2.7.3. PCR Condition 
The PCR condition was described by Ireland and Binepal (1998), amplification 
was achieved by 35 cycles each including a denaturation step at 94Cº for 1 min, 
annealing step at 50Cº for 30 seconds and extension step at 72Cº for 1 min. The final step 
was prolonged to 5 min to ensure complete extension of amplification products. The PCR 
reaction was carried out in a Biometra T3 Thermal cycler (BIOMETRA, Germany). 
          
2.7.4. Detection of PCR product   
The PCR products were separated electrophoretically in 1.5% agarose gel (SIGM) 
(1gm of agarose was dissolved in100 ml TAE buffer) containing Ethidium bromide 
1µl/40ml agarose (PROMEGA, Madison, USA, 10mg/ml). 10µl of 100bp DNA Ladder 
(INVETROGEN) which was prepared by adding 20µl of ladder to 80µl of bromophenol 
blue dye (bromophenol blue 11% + Glycerol 40µl +DDW 50µl) was loaded in the first 
slot of the gel. The 10µl of the PCR products were mixed with 5µl of dye and loaded on 
the rest of the wells. Electrophoresis was performed in a minigel electrophoresis 
(BIOMETRA) using 75 volt for 45 min after the gel was covered with TAE buffer (40 ml 
of 40 m M Tris-HCL pH 8.0+ 20 ml of 20 m M Na acetate) using standard Power Pak 
P25 (BIOMETRA). DNA bands were visualized by fluorescence in UV light using the 
BIODOC ANALYZE gel documentation system BIOMETYRA. 
  
 
 
                                                       CHAPTER III 
                                                       RESULTS 
 
3.1. Epidemiology of sheep and goatpox diseases 
Sheeppox disease originated in early June 2003 in Shutt, east river Atbara and 
Abu Garra region, south of Showak, Gedarif State.   Goatpox was reported in early 
March 2005 in Hillat Kuku, Khartoum State, Sudan. Clinically the two diseases were 
characterized by hyperthermia 40ºC, labored breathing, depression and loss of appetite, 
eruptions on cheeks, nostrils, lips (Fig. 1) and wool free skin like udder (Fig. 2). The 
vesicular stage which was hemorrhagic with a tendency to generalize was followed by 
the development of pustules with later turn into scabs (Fig. 3). Mortality rates vary in 
accordance with the area as shown in Table 3. 
 
Table 3:  Epidemiology of sheep and goatpox infections in Gedarif and Khartoum states 
(2003, 2005).  
Area Animal 
species 
Total 
animals 
No. 
affected 
No. dead Mortality 
1.Shott, 
east river 
Atbara 
 
2.Abu       
Garra, 
south of 
Showak 
 
3.Hillat 
Kuku 
 
Sheep  
 
 
 
 
 
 
 
Sheep 
 
 
 
 
 
Goats 
400 
 
 
 
 
 
 
 
550 
 
 
 
 
 
370 
 
 
30 
 
 
 
 
 
 
 
45 
 
 
 
 
 
35 
 
 
25 
 
 
 
 
 
 
 
37 
 
 
 
 
 
19 
 
 
6.3% 
 
 
 
 
 
 
 
6.7% 
 
 
 
 
 
5.1% 
 
 
Total  1320 110 81 6.1% 
  
All age, sex and breed groups were affected. Age distribution of dead animals is 
shown in Table 4. More than 50% of deaths were reported in young animals in 
comparison to adult sheep.  
 
  Table 4: Age distribution of mortalities due to sheeppox virus infection in Sudan. 
Age group No. affected  No. dead Case fatality rate  
Adult sheep(1-4 
years) 
            32           25           78.1 
Young sheep(3-11 
months) 
           45            40          88.8 
Total           77           65           84.4 
 
 
3.2. Virus isolation  
Two samples yielded virus when 4 tissue homogenates were inoculated onto lamb 
testes cells. The isolates were identified as sheeppox virus and goatpox virus, respectively 
by virus isolation and PCR. The viruses were named SP10 and GP1, respectively. The 
first cytopathic effect (CPE) appeared in passage 4 at 7 days post inoculation (PI). The 
CPE reached 90%  at day 7 of the 6th passage. 
 
3.3. Growth of SPV and GPV on the chorioallantoic membrane (CAM) 
No pock lesions or thickness were observed when goatpox sample (GP1) and 
sheeppox samples (SP1O, SP4) and vaccine strain 0240 were inoculated on embryonated 
chick chorioallantoic membrane (CAM) and harvested 5 days post inoculation. 
 
3.4. Growth of SPV and GPV in cell cultures  
Sheeppox isolate (SP1O) replicated in Vero cells and producing 90% CPE at day 
7 post inoculation was characterized by cells rounding (Fig. 4) and destruction of the 
whole cell sheet. Clear cytopathic effect (CPE) was observed when the SP4 (sheeppox 
isolate) was inoculated on Vero cells starting on the 6th day post inoculation (PI). The 
CPE consisted of round cell formation, retraction and ballooning of cells, nuclear 
vaculation, chromatin fragmentation and loss of continuity of the cells sheet and gave 
80% CPE 7 day post inoculation. GP1 isolate of goatpox produced round cell formation 
and detachment (Fig.5). Three samples of sheeppox (SP1O, SP2 and SP4) and one of 
goatpox isolate (GP1) were inoculated onto MDBK cells. Infected cells showed a few 
round cell formation and 60% CPE 9 days post inoculation. No CPE was observed when 
SP1O and GP1 isolates were inoculated onto CEF cells for 2 passages. 
 
3.5. Titration of SPV 
SP1O isolate of sheeppox was selected for virus titration in Vero cells. The tissue 
culture infective dose 50% (TCID50/ml) was found to be 105.2/ml. 
Table 5: Results of titration of sheeppox  virus according to Reed and Muench (1938) 
Dilution positive Negative Positive 
accumulation
Negative 
accumulation
Rate Percentage
10-1 5 0 18 0 18/18 100 
10-2 5 0 13 0 13/13 100 
10-3 5 0 8 0 8/8 100 
10-4 3 2 3 2 3/5 60 
10-5 0 5 0 7 0/7 0 
10-6 0 5 0 12 0/12 0 
10-7 0 5 0 17 0/17 0 
10-8 0 5 0 22 0/22 0 
 
50% end point 10-4.2 
Proportional distance (P.D) = (Mortality next above 50%) - 50% 
                                    (Mortality next above 50%) – Mortality next blow 50% 
P.D =   60-50%    = 0.2 
            60-0 
ED50 = Log lower dilution in which% mortality next above 50% + P.D X dilution 
factor = -5 + (0.2 X -1) = 5.2 
 
 
3.6. Neutralization of SPV 
Isolate of SP1O was selected to perform neutralization test as confirmatory test 
for diagnosis. The titer Virus-HIS mixture was 103.8/ml. accordingly, the neutralization 
index was calculated to be 1.4. 
Table 6: Results of virus neutralization test for sheeppox  virus. 
 
Dilution Positive  Negative  Positive 
accumulation
Negative 
accumulation 
Rate  Percentage 
10-1 5 0 12 0 12/12 100 
10-2 5 0 7 0 7/7 100 
10-3 2 3 2 3 2/5 40 
10-4 0 5 0 8 0/8 0 
10-5 0 5 0 13 0/13 0 
10-6 0 5 0 18 0/18 0 
10-7 0 5 0 23 0/23 0 
10-8 0 5 0 28 0/28 0 
 
P.D = 100-50% = 0.83 
          100-40 
ED50 = -3 + (0.83 X -1) = 3.83 (Log10) 
The ED50 (NI) = Log10 5.2 – Log10 3.83 = 1.4 
 
3.7. PCR Amplification 
3.7.1. Direct PCR (PCR1) 
3.7.1.1. Direct PCR from skin scabs 
All the three samples (GP2, LSD and SP4) gave negative results (Fig. 6). No 
amplification product was detected when control negative (DDW) was used 
 
3.7.1.2. Direct PCR from cell culture harvest 
The three samples out of six gave positive results (Vaccine strain 0240, SP1O and 
GP1) for viral attachment protein (VAP) gene. Strong bands were detected in the 
Ethidium bromide stained gel that corresponded exactly to the expected DNA band size 
to the (VAP) 192 bp (Fig. 6). No amplification product was detected when control 
negative (DDW) was used as template. 
  
3.7.1. PCR with DNA extracted by phenol-chloroform from skin scabs (PCR2) 
Five samples were tested (GP2, SP1O, GP1, SP4 and LSD). Three samples out of 
five gave positive results (SP1O, GP1 and GP2) for viral attachment protein (VAP) gene. 
Strong bands were detected in the Ethidium bromide stained gel that correspond exactly 
to the expected DNA band size to the (VAP) 192 bp (Fig. 7). No amplification product 
was detected when control negative (DDW) was used as a template. 
 
3.7.2. PCR with DNA extracted by DNA extraction kit from cell culture harvest 
(PCR3) 
Three samples were tested (SP1O, GP1, and vaccine strain 0240). Two out of 
three gave positive result (SP1O, GP1) for viral attachment protein (VAP) gene while 
vaccine strain 0240 gave negative result. Strong bands were detected in the Ethidium 
bromide stained gel that correspond exactly to the expected DNA band size to the (VAP) 
192 bp (Fig. 8). No amplification product was detected when control negative (DDW) 
was used as a template. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Fig. 1 Adult sheep affected by Sheeppox showing pox pustules on the Neck 
 
 
 
 
 
 
 
  
Fig. 2 Adult goat affected by goatpox showing pox scabs and ulcerations on the Udder 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Fig. 3 Adult Saanen goat affected by goatpox showing pox ulcers, pustules and scabs 
on the tail region 
 
 
 
 
 
 
 
 
 
  
 
 
Fig. 4 Vero cells inoculated with SP1O showing rounding of cells at day 7 post 
inoculation 
 
 
 
 
 
 
 
 
 
 
  
        
    Fig. 5 Vero cells inoculated with GP1 showing rounding of cells 
 
 
 
 
 
 
 
 
 
 
 
  
 
Fig. 6 Ethidium bromide stained agarose gel (1.5%). PCR was carried out on DNA 
samples extracted from vaccine strain 0240 and skin scabs of infected sheep and goats by 
boiling using primers (VAP). Lane M: 100bp ladder, lane 1 (SP1O) from cell culture, 
lane 2 (GP1) from cell culture, lane 3 (vaccine strain 0240) from cell culture. Lane 4 
(GP2) from scabs, lane 5 (LSD) from scabs of cattle, lane 6 (SP4) from cell culture, lane 
7 control negative (DDW).   
 
 
 
 
 
 
 
 
  
 
 
Fig. 7 Ethidium bromide stained agarose gel (1.5%). PCR was carried out on DNA 
samples extracted from skin scabs of infected sheep and goats by phenol-chloroform 
using primers (VAP). Lane M: 100bp ladder, lane 1 (GP2) scabs from goat, lane 2 
(SP1O) scab from sheep, lane 3 (GP1) scab from goat. Lane 4 (LSD)cabs from cattle, 
lane 5 (SP4) from sheep  lane 6 control negative (DDW).  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Fig. 8 Ethidium bromide stained agarose gel (1.5%). PCR was carried out on DNA 
samples extracted from skin scabs of infected sheep and goats by Kit using primers 
(VAP). Lane M: 100bp ladder, lane 1 (SP1O) cell culture harvest from sheep, lane 2 
(GP1) cell culture harvest from goat. Lane 3 (vaccine strain 0240) cell culture harvest, 
lane 4 control negative (DDW) 
 
 
 
 
 
 
  
 
CHAPTER IV 
DISCUSSION 
 
Sheep and goatpox diseases are a weighty problem in sheep and goats production. 
In fact they are the most serious of all pox diseases of domestic animals. Sheep and 
goatpox, as highly contagious diseases, needs an urgent accurate laboratory diagnosis, 
once suspected in a herd.  
In the present study three outbreaks of sheep and goat pox that occurred in Al 
Shut and Abu Garra areas of Gedarif State and Khartoum State in June 2003 and March 
2005 respectively were investigated. The clinical diagnosis was confirmed in the 
laboratory by virus isolation and identification or PCR. In the two outbreaks of Gedarif 
State the disease affected sheep population of all ages but in contact goats were not 
affected. The third outbreak occurred in a Saanen herd of imported goats that were 
previously vaccinated against sheeppox. Clinical signs were reported, morbidity rates 
were estimated and the total mortalities were recorded. Clinically, the disease was 
characterized by fever, labored breathing, loss of appetite, depression and eruption of 
generalized pox lesions namely on cheeks, nostrils, lips and wool free skin. The vesicular 
stage which was hemorrhagic with a tendency to generalize followed by the development 
of pustules which later turned into scabs. These clinical signs are similar to those 
described by Kitching and Taylor (1985). Mortality rate ranged between 5.2 and 6.7 with 
a mean of 6.1%. These mortality rates are lower than that described by Rao and 
Bandyopadhyay (2000) who reported a 16% mortality rate in sheep in India. In the third 
outbreak goatpox affected a Saanen herd imported from Holland where sheep and 
goatpox are eradicated. The affected goats were previously vaccinated against sheep and 
goatpox with 0240 vaccine strain locally produced. Infection of this vaccinated goat herd 
points to a vaccination failure. Whether this vaccination failure is due to poor quality 
vaccine or poor application procedure is not   clear. Similar observations of vaccination 
failure were previously reported (Sheikh Ali, 1997).  
In the investigated outbreaks all age, sex and breed groups were affected. 
However, more than 50% of deaths were reported in young animals in comparison to 
adult sheep. These findings are in line with previous observations of sheep and goat pox 
outbreaks (Rao and Bandyopadhyay , 2000). 
Skin Scabs were collected from sick animals, homogenized and inoculated in cell 
culture and embryonated eggs. Two virus isolates were obtained when 4 skin samples 
were inoculated onto Lamb testes (LT) cell culture. These two viruses as well as one 
previous isolate of sheeppox virus (SP 4) and the vaccine strain 0240 induced no lesions 
on the chorioallantoic membrane (CAM) of embryonated chicken eggs. This result agrees 
with Ortitenz and Teicco (1954), Abdulla Khan (1960), Sharma et al. (1966), Adlakha et 
al. (1971), Onar (1971-72), Sen and Uppal (1972), Sharma and Dhanda (1972) and 
Bhatnagar and Gupta, (1974), who failed to propagate sheep poxvirus in chick embryos. 
Goat poxvirus (GPV) isolates differ significantly in their growth behavior in 
embryonated chick eggs (Adlakha et al., 1971; Tantawi and Al-Falluji, 1979).  
Sheeppox virus isolation is difficult; it grows slowly or requires additional 
passages, even if cultured in most sensitive lamb testis (LT) cells. When passaged two to 
three times in these cells it grows easier and faster (Mangana-Vougiouka et al., 1999). In 
the present study skin Scabs were collected from sick animals, homogenized and 
inoculated on cell culture and embryonated eggs. Two virus isolates (one sheeppox virus 
[SP1O] and one goatpox virus [GP1]) were obtained when 4 skin samples were 
inoculated onto Lamb testes (LT) cell culture. Sheeppox and goatpox isolates grew well 
in lamb testes (LT) cell culture with no difference in virus yield or type of CPE produced 
by the two viruses. The two isolates of the viruses (SP1O, GP1) and the vaccine strain 
(0240) as well as one previous isolate of sheeppox virus (SP 4) produced characteristic 
pox cytopathic effects (CPE), such as rounding of cells, retraction and ballooning of cells, 
nuclear vaculation, chromatin fragmentation and loss of continuity of the cells sheet, after 
7 days PI. These findings agreed with Adlakha et al (1971); Joshi et al (1994).  In Vero 
cells, both viruses produced more than 90% CPE within 7 days PI. In MDBK cells 
however, both viruses induced slight CPE that reached 60% in 9 days. On the other hand, 
both viruses induced no CPE in chick embryo fibroblast (CEF) cells.  The growth of 
goatpox strain (GP1) in MDBK cells in our results, agreed with Ved Parkash et al., 
(1994), who reviewed that GPV will grow in the Vero cells and MDBK cell lines. 
Growth of sheeppox strain (SP1O) in Vero cells, agreed with Joshi et al (1995), who 
reviewed that most SPV isolates will grow in MDBK and Vero cells. Our results showed 
that isolation of sheeppox and goatpox viruses require at least three blind passages to be 
possible. This agreed with the report of OIE Manual (2004). SP1O and GP1 isolates 
produced rapid and clear 90% CPE in comparison to the previous isolates (SP4), so that 
SP1O and GP1 were passaged 6 times and this confirmed that additional passages of the 
virus field isolates shows rapid and clear cytopathic effects.  
Titration of an isolate of sheeppox virus (SP1O) was performed in Vero cells and 
resulted in a titre of 105.2/ml. The same virus was identified as sheeppox in virus 
neutralization test with 1.4 neutralization index. The neutralization test was used in this 
study as a confirmatory test for diagnosis of sheeppox and for the purpose of comparing 
the test with polymerase chain reaction (PCR). Vero cells infected with SP1O were used, 
and their results were taken 9 days PI. The results confirmed the identity of 
sheeppoxvirus isolates used in the present study since the test gave a neutralization index 
of 1.4.  
At present the laboratory diagnosis of sheeppoxvirus in the Sudan is based on 
virus isolation and its subsequent identification. These assays are costly, time consuming, 
laborious and some times the interpretation of the results is difficult. Virus isolation on 
susceptible cell culture (LT) cells or Vero cells followed by virus neutralization (VN) or 
immunoflourscence using hyperimmune anti Capripox serum is a lengthy procedure and 
may take two to three weeks.  
These diagnostic problems can be overcome by the use of polymerase chain 
reaction test (PCR) which has considerable potential for detection of Capripoxvirus and 
differentiation from Orf (contagious pustular dermatitis) of sheep (Ireland and Binepal, 
1998; Markoulatos et al., 2000). Highly sensitive molecular biological technique based 
on the PCR are now employed for the identification of many viruses, including GPV and 
SPV in skin biopsies and cell culture (Ireland and Binepal, 1998; Heine et al., 1999; 
Mangana-Vougiouka et al., 1999).  Recently, a PCR assay was reported on cell culture or 
skin biopsy samples (Ireland and Binepal,1998), which compared to an antigen trapping 
enzyme-linked immunosorbent assay (Carn, 1995) and has greater sensitivity and 
specificity. Antigen detection by ELISA may give false-positive results due to 
interference by virus-specific antibodies in the test samples. These antibodies are 
removed from samples for PCR when nucleic acid is released by boiling, phenol-
chloroform extraction or used a polymeric material such as Gene Releaser. The 
oligonucleotide primers pair used for PCR amplification of genomes of either SPV or 
GPV were obtained from the viral envelope protein viral attachment protein (VAP) gene. 
 PCR-diagnostic methods are exceptionally effective for the diagnosis of sheeppox 
and goatpox in suspected skin samples obtained from the field (Rao et al., 2001). 
However, differential diagnosis of goatpox and sheeppox based solely on the PCR 
technique is not yet feasible, but may be possible by restriction enzyme analysis of PCR-
amplified products (Rao and Pandyopadhyay, 2000).  
Polymerase chain reaction (PCR) was used in this study to determine the 
feasibility of improving diagnosis of sheep pox and goat pox in scabs collected from the 
field as well as in supernatant of infected cell cultures. The test was performed according 
to the method described by Ireland and Binepal (1998) using a single primer-pair based 
on sequences coding for the viral attachment protein (VAP) gene. Three methods of DNA 
extraction were tried. The first method (PCR1) employed no DNA extraction step with 
scab homogenate or cell culture supernatant added directly to the PCR mix and heated the 
reaction at 99ºC for 15 minutes to release the DNA and then followed by ordinary 
PCR.This method failed to detect pox virus DNA in all scab homogenates tested but three 
out of six cell culture supernatants gave positive results. In the second method (PCR2), 
viral DNA was extracted by phenol-chloroform from skin scabs; three samples out of six 
gave positive results. In the third method (PCR 3), viral DNA was extracted using a 
commercial DNA extraction Kit; two out of three gave positive result. Accordingly, the 
best PCR method for sheeppox and goatpox diagnosis should include an initial step of 
DNA extraction. 
In the second method (PCR2) DNA was extracted by using phenol-chloroform. A 
total number of five samples from skin scabs were tested. Three out of five samples gave 
positive results (SP1O, GP1, GP2), while two samples (LSD and SP4) gave negative 
results. The DNA band sizes corresponded to the expected size of 192 bp. This method 
seems to be more sensitive than method 1 (PCR1). It is therefore, recommended to use 
this method for routine diagnosis of sheeppox and goatpox in the Sudan. This method 
requires only biopsy materials which are easy to obtain. Cell culture facilities are not 
needed and results can be obtained within 24 hours.  
In the third method (PCR3) viral DNA was extracted by a commercial DNA 
isolation kit from cell culture supernatants and used as templates to conduct PCR. A total 
numbers of three samples (SP1O, GP1 and vaccine strain 0240) were tested. Two out of 
three gave positive results (SP1O and GP1) while no DNA band appeared when the 
vaccine strain 0240 was tested. This method was less sensitive than the second method 
(PCR2). This method is a valuable tool to virus detection. It can replace the lengthy 
method of virus neutralization that requires at least 2 weeks. 
All results of PCR in this study corresponded with Ireland and Binepal (1998) 
who used PCR to detect Capripoxvirus DNA in tissue culture supernatants and biopsy 
samples.  
The PCR-based test is preferable to the neutralization test (VNT) for additional 
reasons than its grater sensitivity. It does not require any reagents that cannot be obtained 
commercially. Many firms sell custom primers for PCR, and all the other reagents are 
common to all PCR reactions. The neutralization test reagents, on the other hand, include 
hyperimmune serum (HIS) which is commercially not available. The PCR test for 
Capripoxvirus in biopsy samples described in this study is a valuable addition to the 
current methods for virus detection.  
Our results suggest that the Capripoxvirus PCR has a diagnostic specificity 
comparable to that of the virus isolation although a much grater number of biopsy 
samples are required to confirm the findings. Although not as robust as the virus 
neutralization (VN), the PCR has additional advantages. The diagnostic sensitivity of the 
PCR is grater than that of virus neutralization test (VNT) and the test can be used later in 
the course of the disease when virus-specific antibodies are present.   
This to our best knowledge is the first investigation using a polymerase chain 
reaction (PCR) for diagnosis of sheep and goatpox virus in Sudan. 
 
 
 
  
CONCLUSION AND RECOMMENDATIONS 
 
Sheep and goatpox are serious diseases that cause heavy economic losses in the 
Sudan. Isolation and identification of sheep and goatpox is expected to open new 
windows in the field of epidemiology and effective control of the disease and 
investigation aiming at comparing local isolates with the 0240 vaccine strain which is 
currently used in the Sudan for the control. Polymerase chain reaction is able to detect 
Capripoxvirus genome in scab materials reducing time required for diagnosis.  Further 
work to be done in future should include PCR followed by sequencing, restriction 
enzyme analysis and a hybridization method for sheep and goatpox isolates (SP1O and 
GP1).  
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APPENDEX 
 
1. Preparation of reagents Solution: 
1.1. Normal Saline (NS): 
 Stock solution of 0.85% (W/V) Na Cl was prepared in DDW and 
autoclaved at 121°C for 20 minutes. 
 
1.2 Preparation of phosphate diluent (PD) 
 Solution A of PBS was completed to 2 litres with DDW, then autoclaved 
and cooled before antibiotics were added. 
 
1.3. Sodium Hydroxide Solution: 
      Na OH                                                                                                        45 gm 
DW                                                                                                             300 ml 
 
 
 
 
 
2. culture media 
2.1. Glasgow Minimum Essential Medium (GMEM) 5x 
 Dissolve the content of one bottle (125.78 gm in two liters of DDW). 
Avoid over stirring and aeration. Filter through Millipore. Filter (0.22µ). Test sterility 
using Thioglycolate medium. Store at -20ºC. 
 
2.1. GMEM 1X: 
 To prepare 1 litre: 
GMEM 5X                                                                                               200 ml 
Yeast extract (1%)                                                                                      25 ml 
Lacalbumin hydrolysate                                                                             25 ml 
Penicillin Strptomycin (105 I.U/ml)                                                           1 ml 
Neomycin (10 mg/ml)                                                                                1 ml 
Mycostatin                                                                                                  1 ml 
Na HCO3 (7.5%) 7.5 ml  
DDW to complete 1000 ml 
 Add 50 ml Tryptose phosphate buffer store at 4ºC. 
 
3. Preparation of Stock Trypsin (2.5%) 
 2.5 grams of trypsin (Gibcol td UK1: 250 Usp Grade) were dissolved in 
100 ml of PD, filtered through What Mann filter and stored at -20°C. 
 
4. Preparation of Stock Versin (5%) 
 Five grams of versin powder were dissolved in 100 ml PD, autoclaved at 
121°C for 15 minutes. 
 
5. Trypsin Versin Solution (T.V) 
 To prepare 100 ml 
Trypsin (2.5%)                                                                                          6.0 ml 
Versin (5%)                                                                                              4.0 ml 
Phosphate Diluent (PD)                                                                          90.0 ml 
 Several drops of phenol red (0.2%) were added and the pH adjusted by IM 
NaOH until the colour is faint pink (slightly alkaline). 
 
6. Preparation of Buffers 
6.1. Glycerol (50%) 
Glycerol                                                                                                         50 ml 
PBS                                                                                                                50 ml 
 
6.2. Formalin (10%) 
Formalin                                                                                                       100 ml 
Na H2PO4                                                                                                      4 gm 
K2 HPO4                                                                                                        6 gm 
Complete to one litre with DDW. 
 
 
 
6.3. Phosphate Buffer Saline (PBS): 
 To prepare 2 litres 
6.3.1. Solution A 
KCl                                                                                                            0.4 gm 
Na Cl                                                                                                         16.0 gm 
Na2 HPO4 (anhydrous)                                                                              2.0 gm  
KH2 PO4                                                                                                  0.4 gm 
DDW                                                                                                         1000 ml 
 
6.3.2. Solution B 
Mg Cl2                                                                                                      0.2 gm 
DDW                                                                                                         200 ml 
 
6.3.3. Solution C 
Ca Cl2                                                                                                       0.26 gm 
DDW                                                                                                         200 ml 
 Autoclave cool and add A to B then C. Complete to 2000 ml with DDW. 
 
7. Phosphate Buffer, pH 8.5 
7.1. Solution A: 
 KH2 PO4 0.5 M (anhydrous, 68.04 gm/litre). 
 
7.2. Solution B: 
K2HPO4 0.5 M (anhydrous, 87.09 gm/litre) take 33 ml/litre from solution A, mix 
with 967 ml/litre from solution B. 
 
8. Tris-EDTA (TE) 
Tris-HCl pH 8                                                                                       10 mM 
EDTA                                                                                                    1Mm 
 
 
9. Media Additives 
9.1. Lacalbumin Hydrolysate 25%: 
 Dissolve 25gm of Lacalbumin enzymatic Hydrolysate in 100 ml DDW and 
keep at 4ºC after sterilization. 
 
9.2. Yeast Extract 1% 
 Dissolve 1 gm of Yeast Extract in 100 ml DDW and keep at 4ºC after 
sterilization. 
 
9.3. Sodium bicarbonate 7.5% 
 Dissolve 0.75 gm of Na HCO3 in 9.5 ml DDW. Add 0.5 ml of 0.2% Phenol 
red. Sterilized by autoclaving at 121ºC for 15 minutes and store at 4ºC. 
 
9.4. Tryptose phosphate broth 29.5 % 
 Dissolve 29.5 gm of powder in 100 ml DDW. Autoclaved at 121ºC for 15 
minutes and stored at 4ºC. 
 
9.5. Antibiotics: 
9.5.1. Penicillin-Streptomycin Solution: 
 One gram of streptomycin powder and the contents of 2 vials of penicillin 
(1000000 IU/vial) were dissolved in 10 ml of sterile deionized distill water (DDW) to 
give solution contained 100 mg streptomycin and 200000 IU penicillin per ml. The 
solution was kept at -20ºC. 
 
9.5.2. Kanamycin Solution: 
 One gram of kanamycin powder (equivalent to 700000 IU) was dissolved 
in 13.3 ml of sterile DDW to give a concentration of 52500 U/ml and kept at -20ºC. 
9.5.3. Fungizon Solution: 
 The content of one vial of fungizon (50000 µg) was dissolved in 10 ml of 
sterile DDW and kept at 4ºC. 
9.5.4. Mycostatin Solution: 
 The content of one vial of mycostatin (50000 µg) was dissolved in 10 ml of 
sterile DDW and kept at 4ºC. 
 
9.6. Bovine serum: 
 Calves were bled from the jugular vein. The whole blood was left overnight 
at room temperature. The separated serum was centrifuged at 2000 rpm for 10 
minutes, then filtered through a Seitz filter under negative pressure. The filtrate was 
passed through a Millipore filter (0.22 µ) under positive pressure and then tested for 
sterility by culturing on Thioglycolate medium in two vials, one of them was 
incubated at 37ºC and another one at room temperature for two days. Then the sterile 
serum was kept at -20ºC. 
 
10. Thioglycolate medium: 
 29.5 gm of Thioglycolate medium were dissolved in 1000 ml of DDW. The 
solution was heated in steamer to ensure complete dissolving and then dispensed in 
bjoux bottles. The medium was sterilized by autoclaving at 121º. 
 
11. PCR Master mix: 
10X PCR Buffer                                                                                     5.0 µl 
Mg Cl2 50 mM                                                                                       3.0 µl 
dNTPs 10-11 mM                                                                                  1.0 µl 
Mg SO4 5mM                                                                                        15.0 µl 
DDW                                                                                                       16.0 µl 
Total                                                                                                        40.0 µl 
 
12. Preparation of materials for gel electrophoresis: 
12.1.  TAE buffer 
40 mM Tris HCl (pH 8.0)                                                                           40 ml 
20 mM Na acetate                                                                                       20 ml 
EDTA powder (292.25 MW) 5845 gm 
Complete to one litre 
                                                                                                                                                     
12.2.  Loading Dye: 
Bromophenol Blue (11%)                                                                        10 µl 
Glycerol                                                                                                    40 µl 
DDW                                                                                                         50 µl 
 
12.3.  1.5% agarose gel: 
                                                                                                    
                 1.5 gram of agarose (SIGMA) was dissolved in 100 ml TAE buffer.                              
The mixture was melted in a microwave oven for 60 seconds, cooled down. 1.5 µl 
Ethidium bromide was added at a final dilution of 0.2 µg/µl and swirled. Poured on a 
plate. The comb was placed and the gel was left to solidify. 
 
12.4. 100 bp DNA Ladder (INVITRGEN): 
Ladder (1.0 ug/ul)                                                                                           20 µl 
Blue dye                                                                                                          80 µ l  
 
12.5. Ethidium bromide: 
Stock Solution (PROMEGA, Madison)                                                  10 mg/ml                                
                      And protected from light. 
 
 
 
 
                                                                
 
 
  
 
 
 
 
                                                                                                                                                                              
                                                                 
 ﻣﻠﺨﺺ اﻻﻃﺮوﺣﺔ                                                                                     
  
واﻟﺘﻰ ﺗﺴﺒﺒﻬﺎ ﻓﻴﺮوﺳﺎت ( xoptaoG)وﺟﺪرى اﻟﻤﺎﻋﺰ( xoppeehS)ﻳﻌﺘﺒﺮ آﻞ ﻣﻦ ﻣﺮﺿﻰ ﺟﺪرى اﻟﻀﺎن 
 اﻻﻣﺮاض اﻟﺠﻠﺪﻳﺔ ﻓﻰ اﻻﻏﻨﺎم واﻟﻤﺎﻋﺰ واﻟﺘﻰ ﺗﺤﺪث ﺧﺴﺎﺋﺮ ، ﻣﻦ اهﻢ( eadirivxoP)ﺗﻨﺘﻤﻰ ﻟﻌﺎﺋﻠﺔ اﻟﺠﺪرى اﻟﻔﻴﺮوﺳﻴﻪ 
  .اﻗﺘﺼﺎدﻳﺔ آﺒﻴﺮة وﻗﻠﻪ ﻓﻰ اﻻﻧﺘﺎج 
اﺟﺮﻳﺖ هﺬﻩ اﻟﺪراﺳﺔ ﻟﻤﻌﺮﻓﺔ ﺗﺸﺨﻴﺺ ﻣﺮﺿﻰ ﺟﺪرى اﻟﻀﺎن وﺟﺪرى اﻟﻤﺎﻋﺰ ﻋﻦ ﻃﺮﻳﻖ ادﺧﺎل ﺗﻔﺎﻋﻞ 
  . ﺣﺪﻳﺜﺔ ﺑﺪﻻ ﻣﻦ اﻟﻮﺳﺎﺋﻞ اﻟﺘﻘﻠﻴﺪﻳﺔ اﻟﻤﺴﺘﺨﺪﻣﻪ ﻮﺳﻴﻠﺔاﻟﺒﻠﻤﺮة اﻟﻤﺘﺴﻠﺴﻞ آ
 اﺑﻮ ﻗﺮع ﺟﻨﻮب اﻟﺸﻮك وﻣﻨﻄﻘﺔ ﺷﻮت ﺷﺮق ﻧﻬﺮ ﻋﻄﺒﺮة ، ﺷﺮق اﻟﺴﻮدان وﻻﻳﺔ ﺗﻢ اﺧﺬ ﻋﻴﻨﺎت ﻣﻦ ﻣﻨﻄﻘﺘﻰ
اﻟﻘﻀﺎرف ﻣﻦ اﻏﻨﺎم ﻟﻮﺣﻆ ﻋﻠﻴﻬﺎ ﻋﻼﻣﺎت اﻟﻤﺮض وﺗﻢ ﺗﻘﺪﻳﺮ ﻣﻌﺪل اﻟﻤﺮاﺿﻪ وﺗﻢ رﺻﺪ ﻣﻌﺪل اﻟﻨﻔﻮق اﻟﻜﻠﻰ ﻃﻮال ﻓﺘﺮة 
 اﻻﻋﻤﺎر ﻧﺴﺒﺔ  ﻣﻦ اﻟﻨﻔﻮق  ﻟﻮﺣﻆ ﻓﻰ% 05اﻇﻬﺮت اﻟﻨﺘﺎﺋﺞ ان ﺣﻮاﻟﻰ اآﺜﺮ ﻣﻦ  .اﻟﻤﺮض وذﻟﻚ ﻟﺘﺤﺪﻳﺪ ﻧﺴﺒﺔ اﻟﻨﻔﻮق 
  .رﻧﺔ ﺑﺎﻻﻋﻤﺎر اﻟﻜﺒﻴﺮة ﻓﻰ اﻻﻏﻨﺎماﻟﺼﻐﻴﺮة ﻣﻘﺎ
 ﻇﻬﻮر ﺗﻔﺸﻰ ﺪﺗﻢ اﺧﺬ ﻋﻴﻨﺎت ﻣﻦ ﻣﺎﻋﺰ ﻣﺸﺮوع اﻟﺴﻌﺎﻧﻴﻦ ﻣﻦ ﻣﻨﻄﻘﺔ ﺣﻠﺔ آﻮآﻮ وﻻﻳﺔ اﻟﺨﺮﻃﻮم ﺑﻌآﻤﺎ  
 ، وﺗﻢ ﺗﺤﺪﻳﺪ ﻣﻌﺪل اﻟﻨﻔﻮق وﻣﻌﺪل 0420ﻟﻠﻤﺮض ﻋﻠﻤﺎ ﺑﺎن اﻟﺤﻴﻮاﻧﺎت ﺣﻘﻨﺖ ﺑﻠﻘﺎح ﺟﺪرى اﻟﻤﺎﻋﺰ واﻻﻏﻨﺎم ﻋﺜﺮة 
ت اﻟﻤﺼﺎﺑﺔ وﺗﻢ اﻋﺪاد اﻟﻌﻴﻨﺎت ﻧﺎاوﻋﻘﺪ ﺟﻠﺪﻳﺔ وﻣﺴﺤﺎت اﻧﻔﻴﺔ ﻣﻦ اﻟﺤﻴﻮﻨﺎت ﻗﺸﻮر ﺟﻠﺪﻳﺔ وآﺸﻄﺎت ﺗﻢ اﺧﺬ ﻋﻴ. اﻟﻤﺮاﺿﻪ 
 ﺑﺴﺤﻨﻬﺎ وﻣﻌﺎﻣﻠﺘﻬﺎ ﺑﺎﻟﻤﻀﺎدات اﻟﺤﻴﻮﻳﻪ وﺗﻢ ﺗﺰرﻳﻌﻬﺎ ﻓﻰ اﺟﻨﺔ اﻟﺒﻴﺾ اﻟﻨﺎﻣﻴﺔ وﺧﻼﻳﺎ ﺧﺼﻰ اﻟﺤﻤﻼن اﻻﺑﺘﺪاﺋﻴﺔ وﺧﻼﻳﺎ
اﻇﻬﺮت اﻟﻌﻴﻨﺎت ﺗﺄﺛﻴﺮات ﻣﺮﺿﻴﻪ . ﻳﺮاتوﺗﻢ ﺗﻤﺮﻳﺮهﺎ ﻟﻌﺪد ﺳﺘﻪ ﺗﻤﺮاﻟﻤﺴﺘﻤﺮة  oreV   اﻟﻤﺴﺘﻤﺮة ﺛﻢ ﻓﻰ ﺧﻼﻳﺎKBDM
هﺬﻩ ﺑﻤﻘﺎرﻧﺔ  .ﻋﺒﺎرة ﻋﻦ اﺳﺘﺪارة اﻟﺨﻼﻳﺎ واﻧﺘﻔﺎﺧﻬﺎ وﺗﺤﻄﻤﻬﺎ  وذﻟﻚ ﺑﻌﺪ ﺳﺒﻌﺔ اﻳﺎم ﻣﻦ اﻟﺤﻘﻦ% 09ﻓﻰ اﻟﺰرع اﻟﺨﻠﻮى  
 آﻤﺎ اﻧﻪ ﻟﻢ ﺗﺤﺪث ﻟﻜﻦ ﺑﻌﺪ اﻟﺘﻤﺮﻳﺮ ﻓﻰ ﺧﻼﻳﺎ ﺧﺼﻴﻪ اﻟﺤﻤﻼن و oreV ﻟﻮﺣﻆ ﻇﻬﻮر ﺗﻐﻴﺮات ﻣﺮﺿﻴﻪ ﻓﻰ ﺧﻼﻳﺎ اﻟﻨﺘﺎﺋﺞ 
  .ﻧﻪ ﺑﻨﻔﺲ اﻟﻌﻴﻨﺎت اﻟﻤﺮﺿﻴﺔ واﻟﻠﻘﺎحﺔ ﻓﻰ اﺟﻨﺔ اﻟﺒﻴﺾ اﻟﻤﺤﻘﻮاى ﺗﻐﻴﺮات ﻣﺮﺿﻴ
 وﻣﻌﺎﻳﺮة ﺗﻢ ﺗﺸﺨﻴﺺ اﻟﻌﻴﻨﺎت ﻋﻦ ﻃﺮﻳﻖ اﻟﻌﺰل ﻓﻰ اﻟﺰرع اﻟﺨﻠﻮى وﺗﺄآﻴﺪﻩ ﻋﻦ ﻃﺮﻳﻖ اﺧﺘﺒﺎر اﻟﺘﻌﺎدل اﻟﻔﻴﺮوﺳﻰ
ﺑﺎﺳﺘﺨﺪام ﻣﺼﻞ ﻣﻤﻨﻊ ﻟﺠﺪرى اﻻﻏﻨﺎم واﻋﻄﻰ  رﻗﻢ ﺗﻌﺎدل اﺧﺘﺒﺎر اﻟﺘﻌﺎدل اﻟﻔﻴﺮوﺳﻰ اآﺪ ان اﻟﻔﻴﺮوس ﻣﻮﺟﺒﺎ  .اﻟﻔﻴﺮوس 
  lm/2.501. آﻤﺎ آﺎن ﻣﻌﻴﺎر اﻟﻔﻴﺮوس اﻟﻤﺤﺪث ﻟﻠﺘﻐﻴﺮات اﻟﻤﺮﺿﻴﺔ ﻓﻰ  اﻟﺰرع اﻟﺨﻠﻮى 4.1
ادﺧﻞ آﻮﺳﻴﻠﺔ ﺣﺪﻳﺜﺔ ﻟﺘﺸﺨﻴﺺ ﺟﺪرى اﻟﻀﺎن  واﻟﻤﺎﻋﺰ ﻣﻦ  ﺗﻔﺎﻋﻞ اﻟﺒﻠﻤﺮة اﻟﻤﺘﺴﻠﺴﻞ اﻟﻤﺴﺘﺨﺪم ﻓﻰ هﺬ ﻩ اﻟﺪراﺳﺔ
ﻟﻨﻮوى ﻣﻨﻘﻮص ﺗﻢ اﺳﺘﺨﻼص اﻟﺤﻤﺾ ا. اﻟﻘﺸﻮر اﻟﺠﻠﺪﻳﺔ  ﻟﻠﺤﻴﻮاﻧﺎت اﻟﻤﺼﺎﺑﺔ ، و آﺬﻟﻚ ﻣﻦ ﺣﺼﺎد اﻟﺰرع اﻟﺨﻠﻮى 
 -: ﺑﻮاﺳﻄﺔ ﺛﻼﺛﻪ ﻃﺮق ﻣﺨﺘﻠﻔﺔ ﻟﻠﻔﻴﺮوس( AND )اﻻوآﺴﺠﻴﻦ
 هﺬﻩ اﻟﻄﺮﻳﻘﺔ ﻓﺸﻠﺖ ﻓﻰ اآﺘﺸﺎف . ﻣﻦ ﻗﺸﻮر ﺟﻠﺪﻳﺔ و ﺣﺼﺎد زرع ﺧﻠﻮيﻣﺒﺎﺷﺮة ﻣﻦ اﻟﻤﻌﻠﻖ اﻟﻤﺘﺠﺎﻧﺲ ﻟﻠﻔﻴﺮوس. 1
ﻣﻦ ﺣﺼﺎد اﻟﻔﻴﺮوس ﻣﺒﺎﺷﺮة ﻣﻦ اﻟﻘﺸﻮر اﻟﺠﻠﺪﻳﻪ ﻟﻠﻤﻌﻠﻖ اﻟﻤﺘﺠﺎﻧﺲ ﻟﻠﻌﻴﻨﺔ ﺑﻴﻨﻤﺎ ﺗﻢ اآﺘﺸﺎف ﺛﻼﺛﺔ ﻋﻴﻨﺎت ﻣﻮﺟﺒﺔ ﻟﻠﻔﻴﺮوس 
  . اﻟﺰرع اﻟﺨﻠﻮى 
ﻣﻦ اﻟﻘﺸﻮر  ﻋﻦ ﻃﺮﻳﻖ اﻟﻜﻠﻮروﻓﻮرم واﻟﻔﻴﻨﻮل (AND )اﺳﺘﺨﻼص اﻟﺤﻤﺾ اﻟﻨﻮوى ﻣﻨﻘﻮص اﻻوآﺴﺠﻴﻦ. 2
  .  وهﺬﻩ اﻟﻄﺮﻳﻘﺔ اﻇﻬﺮت وﺟﻮد ﺛﻼﺛﺔ ﻋﻴﻨﺎت ﻣﻮﺟﺒﻪ ﻣﻦ ﺳﺘﻪ ﻋﻴﻨﺎت ﻣﻦ اﻟﻘﺸﻮر اﻟﺠﻠﺪﻳﺔ .اﻟﺠﻠﺪﻳﺔ
ﻟﻄﺮﻳﻘﻪ ﺗﻢ اآﺘﺸﺎف ﻋﻴﻨﺘﻴﻦ ﻣﻮﺟﺒﺘﻴﻦ ﻓﻰ هﺬﻩ ا.  ﻣﻦ ﺣﺼﺎد اﻟﺰرع اﻟﺨﻠﻮى tik noitcartxe AND   ﺑﻮاﺳﻄﺔ. 3
 ﻳﻌﻄﻰ ﻧﺘﻴﺠﻪ ﺳﺎﻟﺒﻪ  ﻣﻦ 2420ﻟﻔﻴﺮوﺳﻰ ﺟﺪرى اﻟﻀﺎن واﻟﻤﺎﻋﺰ ﺑﻴﻨﻤﺎ وﺟﺪ ان ﻟﻘﺎح ﺟﺪرى اﻟﻤﺎﻋﺰ واﻟﻀﺎن ﻋﺜﺮة 
 .ﺣﺼﺎد اﻟﺰرع اﻟﺨﻠﻮى وﻣﺒﺎﺷﺮة ﻣﻦ اﻟﻤﻌﻠﻖ اﻟﻔﻴﺮوﺳﻰ ﻟﻠﻘﺎح 
 ﺳﻴﻪ ﻣﻦ اﻟﺘﻌﺎدل اﻟﻔﻴﺮوﺳﻰ اﺛﺒﺖ اﻧﻪ اآﺜﺮ ﺣﺴﺎ آﻤﺎاﺧﺘﺒﺎر ﺗﻔﺎﻋﻞ اﻟﺒﻠﻤﺮة اﻟﻤﺘﺴﻠﺴﻞ اﻇﻬﺮ ﻧﺘﺎﺋﺞ ﻣﻮﺟﺒﺔ ﻟﻠﻌﻴﻨﺎت
    .واﺳﺮع ﻣﻨﻪ
وﻓﻘﺎ ﻟﻬﺬﻩ اﻟﻨﺘﺎﺋﺞ وﺟﺪ اﻧﻪ اﻓﻀﻞ ﻃﺮﻳﻘﺔ ﻻﺟﺮاء اﺧﺘﺒﺎر ﺗﻔﺎﻋﻞ اﻟﺒﻠﻤﺮة اﻟﻤﺘﺴﻠﺴﻞ ﻟﺘﺸﺨﻴﺺ ﺟﺪرى اﻟﻀﺎن واﻟﻤﺎﻋﺰ 
  .(AND)ﻳﺠﺐ ان ﺗﻀﻢ ﺧﻄﻮةﻻﺳﺘﺨﻼص اﻟﺤﻤﺾ اﻟﻨﻮوى ﻣﻨﻘﻮص اﻻوآﺴﺠﻴﻦ 
  
 
         
 
 
 
 
 
 
